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 Friend of GATA-1 (FOG-1) is a member of the friend of GATA (FOG) 
family of proteins, which consists of large multitype zinc finger cofactors that 
bind to the amino zinc finger of GATA transcription factors and modulate their 
activity. FOG-1 also interacts with the C-terminal binding protein (CtBP), 
mainly known as a corepressor and the nucleosome remodelling and histone 
deacetylase repressive (NuRD) complex ; thus, integrating FOG-1 into the 
transcription factor and chromatin modifier networks. Remarkably, the protein 
activates or represses gene transcription by facilitating binding of GATA 
factors to DNA, recruiting chromatin remodelling complexes, or by stabilizing 
tissue-specific chromatin loops. Physical interaction between FOG and GATA 
proteins in vivo is essential for the development of a broad array of tissues, 
reflecting the overlapping expression patterns of these factors. Notably, within 
the haematopoietic system, FOG-1 is absent in most of the myeloid lineages ; 
it is expressed at high level in multipotent progenitors, erythroid and 
megakaryocytic cells, low level in lymphoid and haematopoietic stem cells. 
The cofactor is essential for differentiation of the erythroid and 
megakaryocytic lineages, notably by interacting with GATA-1. FOG-1 also 
plays a role in the T-lineage by repressing GATA-3 dependent induction of 
Th2 development. Interestingly, overexpression of FOG-1 in avian 
eosinophils, which do not normally express FOG-1, reprograms these 
differentiated cells into multipotent cells. To study FOG-1 in mammals, we 
used a novel transgenic mouse model strategy which we had designed to 
generate mice with conditional overexpression of FOG-1. Our work with 
enforced expression of FOG-1 in the whole murine haematopoietic system led 
to a reduction in the number of circulating eosinophils, confirming and 
extending to mammals the previously reported role of FOG-1 in repressing 
this lineage development. Strikingly, we have identified the expression of 
FOG-1 in early B lymphocytes, but not in late developmental stages such as 
mature B cells and plasma cells. Moreover, FOG-1 function had never been 
described in the B-lineage, where GATA factors are not expressed. Therefore, 
we were intrigued by both the regulated expression of FOG-1 during B cell 
development and its molecular mechanism of action in the absence of GATA 
factors. Thus, we generated transgenic mice in which FOG-1 expression was 
enforced at a physiologically relevant level in the B lymphoid system : in 
mature B cells and from early B cell stages. We found that sustained FOG-1 
expression in mature and late B cells did not affect their development or 
function, contrary to our expected hypothesis. Although the mice 
overexpressing FOG-1 from early B cell lineages showed only a weak 
phenotype, we extensively studied FOG-1 partners in early B cell stages. 
Indeed, describing FOG-1 molecular mechanism of action in the absence of 
GATA factors is a question that warrant further investigation. We notably 
found FOG-1 in complex with Ikaros, a transcription factor well described as 
crucial for B cell development. The cofactor was also found associated to the 
CtBP and NuRD epigenetic complexes in B cell lines. 
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Chapter 1 : Introduction 
 
 The human organism is a complex set of numerous organs, which are 
themselves a set of tissues ; all composed of billions of cells in various stages 
of differentiation. Its homeostasis, of which any deregulation can lead to 
pathology, depends on appropriate cellular development and communication. 
Thus, understanding precisely how cell differentiation occurs, notably inside 
the haematopoietic system is a crucial question from both a fundamental and 
applied point of view. 
 Since many years, scientists have developed projects implying model 
organisms (for instance, Mus musculus) in order to study pathological 
situations. Especially, genetically modified mice with loss- or gain-of-function 
for a particular gene have been established. Besides, in human and mouse 
organisms, the haematopoietic tree constitutes a useful system for dissecting 
cell differentiation. Indeed, thanks to the expression of given cell surface 
markers, one can isolate step after step the differentiating cells by flow 
cytometry. The haematopoietic cell differentiation is under the control of 
various transcription and epigenetic factors ; whose expression can be 
genetically manipulated in an entire organism as precised before. 
 During the course of my thesis, I focused on the role of the 
transcriptional cofactor Friend of GATA-1 (FOG-1) in mammals. Different mice 
lines were generated and analyzed : some overexpressed FOG-1 in the whole 
haematopoietic system, which is presented at the beginning of the 
introduction. Others were knockdown for or overexpressed FOG-1 specifically 
in the B cell lineage. Inside the haematopoietic tree, T and B lineages share 
common characteristics which are exposed further in the introduction. Patrick 
Matthias’ laboratory aims at understanding the molecular interplay of 
transcription and epigenetic factors during B cell development. These 
networks within B cells are described in a second part of the introduction. 
Finally, a statement on what is already known in the litterature on FOG-1 
function in the haematopoietic system constitutes the third part of the 
introduction. 
 
1. The haematopoietic system 
 
 The haematopoietic system or, in other words, the bodily system of 
organs and tissues involved in the formation and functioning of blood 
elements is the site of haematopoiesis. It includes the bone marrow, spleen, 
thymus, tonsils and lymph nodes. 
 Stem cells can divide either to produce more stem cells (self-renewal) 
or to replenish differentiated cells. The critical stem cell in haematopoiesis is 
the pluripotential haematopoietic stem cell, often referred to simply as the 
haematopoietic stem cell (HSC). All mature haematopoietic cells are 
generated from HSCs by stepwise differentiation into intermediate precursors 
with increasingly restricted differentiation potential (Fig. 1 (Orkin and Zon, 
2008)). 
 Within the haematopoietic system, the myeloid system is defined in 
opposition to the lymphoid system or adaptive immune system. The following 




















Figure 1 : Differentiation of haematopoietic stem cells (HSCs) to the different myeloid and lymphoid lineages. In 
definitive haematopoiesis, long-term HSCs (LT-HSCs) give rise to short-term HSCs (ST-HSCs). ST-HSCs produce 
common myeloid progenitors (CMPs) and common lymphoid progenitors (CLPs). CMPs give rise to 
megakaryocyte/erythroid progenitors (MEPs) and granulocyte/macrophage progenitors (GMPs), whereas CLPs are 
the source of committed precursors of B and T lymphocytes. GMPs give rise to the committed precursors of mast 
cells, eosinophils, neutrophils, and macrophages. The transcription factors that govern haematopoiesis in the 
mammals are depicted. The stages at which haematopoietic development is blocked in the absence of a given 
transcription factor, as determined through gene knockouts, are indicated by red loops. The factors depicted in red 
have been associated with oncogenesis. Factors in grey have not yet been found translocated or mutated in 








whose one of the physiological function is the defense against pathogens 
(antigens, Ag) invading the body. 
 
1.1. The myeloid system 
 
 After bifurcation between the myeloid and lymphoid lineage, the 
common myeloid progenitor cell, or CMP produces the 
megakaryocyte/erythroid progenitor cell (MEP), which can generate either the 
red blood cell (RBC or erythrocyte) lineage or the platelet lineage. The CMP 
can also give rise to the granulocyte/monocyte progenitor cell (GMP), which 
generates the basophils/mast cells, eosinophils, neutrophils, and 
monocytes/macrophages. Eventually, MEPs and GMPs produce precursor 
cells that can divide but produce only one type of cell in addition to renewing 
themselves. 
 The erythroid precursor cell is a committed stem cell that can form only 
RBCs. Its immediate progeny is capable of responding to the hormone 
erythropoietin to produce the first recognizable differentiated member of the 
erythrocyte lineage, the proerythroblast, a RBC precursor. This cell begins to 
make globin (Krantz and Goldwasser, 1965a, b). As the proerythroblast 
matures, it becomes an erythroblast, synthesizing enormous amounts of 
hemoglobin. The mammalian erythroblast eventually expels its nucleus and 
becomes a reticulocyte. Although reticulocytes, lacking a nucleus, can no 
longer synthesize globin messenger RNA (mRNA), they can translate existing 
messengers into globins. The final stage of differentiation of the erythroid 
lineage is the erythrocyte, or mature RBC. In this cell, no division, RNA 
synthesis, or protein synthesis takes place. The DNA of the erythrocyte 
condenses and is not transcribed anymore. Amphibians, fishes and birds 
retain the functionless nucleus ; mammals extrude it from the cell. The 
erythrocyte then leaves the bone marrow and enter the circulation, where it 
delivers oxygen to the body tissues (Gilbert, 2010). 
 During megakaryocytopoiesis, a primitive megakaryocyte progenitor 
cell differentiate and produce colony-forming unit-megakaryocytes (CFU-
MKs), which are then giving rise to megakaryocytes (MKs). These latter are 
multinucleate cells (containing up to 20 nuclei) from which platelets are 
derived. Platelets are small, colorless, irregularly shaped nonnucleated cells. 
The primary role of platelets is to mediate blood clotting, but activated 
platelets also secrete cytokines that influence the functions and migration of 
other leukocytes during an inflammatory response. The cytokines are 
produced from performed mRNAs that are translated upon platelet activation 
(Saunders, 2006). 
 Macrophages are resident in almost all tissues and are the mature form 
of monocytes, which circulate in the blood and continually migrate into 
tissues, where they differentiate. Together, monocytes and macrophages 
make up one of the three types of phagocytes in the immune system : the 
others are the granulocytes (the collective term for the white blood cells called 
neutrophils, eosinophils, and basophils) and the dentritic cells (DCs). 
Macrophages are relatively long-lived cells and perform several different 
functions throughout the innate immune response and the subsequent 
adaptive immune response. One is to engulf and kill invading microorganisms. 




immunity and also dispose of pathogens and infected cells targeted by an 
adaptive immune response. Both monocytes and macrophages are 
phagocytic, but, as most infections occur in the tissues, it is primarily 
macrophages that perform this important protective function. An additional 
and crucial role of macrophages is to orchestrate immune responses : they 
help induce inflammation, which is a prerequisite to a successful immune 
response, and they secrete signalling proteins that activate other immune-
system cells and recruit them into an immune response. As well as their 
specialized role in the immune system, macrophages act as general 
scavenger cells in the body, clearing dead cells and cell debris. 
 In addition to the committed precursor of monocytes and macrophages, 
GMPs give rise to the committed precursors of neutrophils, eosinophils, 
basophils and mast cells. 
The granulocytes are so called because they have densely staining granules 
in their cytoplasm. There are three types of granulocytes –neutrophils, 
eosinophils and basophils-, which are distinguished by the different staining 
properties of the granules. In comparison with macrophages, they are all 
relatively short-lived, surviving for only a few days and are produced in 
increased numbers during immune responses. At that time, they leave the 
blood to migrate to sites of infection or inflammation. The phagocytic 
neutrophils are the most numerous and most important cells in innate immune 
responses : they take up a variety of microorganisms by phagocytosis and 
efficiently destroy them in intracellular vesicles using degradative enzymes 
and other antimicrobial substances stored in their cytoplasmic granules. The 
protective functions of eosinophils and basophils are less well understood. 
Their granules contain a variety of enzymes and toxic proteins, which are 
released when the cell is activated. Eosinophils and basophils are thought to 
be important chiefly in defense against parasites, which are too large to be 
ingested by macrophages or neutrophils, but their main medical importance is 
their involvement in allergic inflammatory reactions, in which their effects are 
damaging rather than protective. 
Mast cells, whose blood-borne precursors are not well defined, differentiate in 
the tissues. Although best known for their role in orchestrating allergic 
responses, they are believed to play a part in protecting the internal surfaces 
of the body against pathogens and are involved in the response to parasitic 
worms. They have large granules in their cytoplasm that are released when 
the mast cell is activated ; these help induce inflammation (Kenneth M. 
Murphy, 2008a). 
 Apart from cells belonging to the myeloid lineage, able to carry out 
innate immune responses, cells of the lymphoid lineage are in charge of the 
adaptive immune responses. Cells considered to be of the lymphoid lineage 
include T and B lymphocytes, natural killer (NK) cells, and natural killer T 
(NKT) cells. T- and B-lymphopoiesis are described in the following section. 
 
 1.2. The lymphoid system 
 
 The major effector cells of the adaptive immune responses are the T 
and B lymphocytes that arise from a common lymphoid progenitor cell (CLP), 




adulthood, in the bone marrow. Both T and B cells bear highly diverse 
receptors on their cell surface that are able to recognize a vast diversity of Ag. 
Both share an ordered rearrangement of their Ag receptor genes, obligatory 
expression of a surrogate, invariant component of their pre-receptors, and 
ligand-dependent positive and negative selection of their mature Ag receptor 
repertoires. Each cell is genetically programmed to encode unique cell 
surface receptors specific for a particular Ag. The T cell Ag receptor (TCR) is 
a membrane-bound molecule related to immunoglobulin (Ig), which 
recognizes a complex of a peptide fragment bound to a molecule specialized 
in Ag presentation, a major histocompatibility complex (MHC) molecule. The B 
cell Ag receptor (BCR) is the membrane-bound form of an antibody (Ab or Ig) 
that would be secreted upon activation of the cell. Each B cell presents only 
one type of BCR on its surface. 
 
  1.2.1. T-lymphopoiesis 
 
   1.2.1.1. Main stages of T cell development in the thymus 
 
 As mentioned before, T cells originate from HSCs and develop in the 
thymus, through a process that can be separated into three broad steps (Fig. 
2 (Carpenter and Bosselut)). The first spans thymic colonization to T cell 
commitment ; the second proceeds to the divergence of αβ and γδ lineages. 
The third step sees αβ and γδ lineage cells complete their differentiation and 
acquire immunological properties and, in some cases, effector functions. In 
more details, HSCs can give rise to early T cell progenitors (ETP), that 
migrate to the thymus, the main site of the T cell development. The loss of 
multipotency that defines T commitment is a gradual process. It occurs in 
double negative (DN) thymocytes, which do not express neither CD4 nor CD8 
– a subset that is itself separated into four sequential phenotypic stages on 
the basis of CD44 and CD25 expression (DN1 : CD44+CD25-, DN2 : 
CD44+CD25+, DN3 : CD44-CD25+ and DN4 : CD44-CD25-) – and is not 
complete before the DN2 stage. ETPs are part of a heterogeneous DN1 
subset that includes both subsequent intermediates in the T cell differentiation 
pathway and cells belonging to DC, myeloid (M) or NK lineages. The DN2 and 
DN3 subsets are themselves divided into two stages, based on expression of 
the receptor c-Kit and of CD27, respectively. αβ lineage cells emerge from β-
selection as double-positive (DP) and are the precursors of conventional CD4 
and CD8 cells. The developmental progression of these cells is notably 
marked by a positive selection consisting in the rescue from programmed cell 
death of DP thymocytes as a consequence of TCRαβ interaction with self 
peptide-MHC complexes expressed by the thymic epithelium (or with other 
MHC or MHC-like molecules). Most αβ lineage cells undergo a MHC-induced 
selection which results in the differentiation of ‘single-positive’ (SP) 
thymocytes that express either CD4 or CD8, two molecules that contribute to 
TCR recognition of MHC class II or MHC class I, respectively ; such SP 
thymocytes are the direct precursors of mature T cells. Whereas the vast 
majority of αβ T cells are restricted by MHC class I or MHC class II molecules, 
as detailed before, small subsets are selected on other MHC or MHC-like 
































Figure 2 : Overview of T cell development, depicting thymic developmental stages. Expression of CD4 and CD8 
separates CD4-CD8- double-negative (DN), CD4+CD8+ double-positive (DP) and single-positive (SP) cells, whereas 
the expression of CD44 and CD25 defines four DN subsets : CD44+CD25- (DN1), CD44+CD25+ (DN2), CD44-CD25+ 
(DN3) and CD44-CD25- (DN4). The earliest precursors that enter the thymus derive from haematopoietic stem cells 
(HSCs) in the bone marrow and are known as early T cell progenitors (ETP). They are part of a heterogeneous DN1 
subset that includes both subsequent intermediates in the T cell differentiation pathway and cells belonging to 
dendritic (DC), myeloid (M) or natural killer (NK) lineages. The DN2 and DN3 subsets are themselves divided into two 
stages, based on expression of the receptor c-Kit and of CD27, respectively. Critical checkpoints are shown in red. 
Cell subsets are grouped according to key developmental steps : early uncommitted progenitors (blue), T cell 
committed progenitors before the separation of αβ and γδ lineages (pink) and cells commited to the αβ (yellow) or γδ 





















recognize lipid-bound MHC class I-like CD1d molecules. In addition to the 
positive selection, a negative one consists in the elimination of self-reactive 
cells, which is the cause of extensive cell death in the thymus. The main 
stages of thymic T cell development, which takes place in the thymus are 
depicted in the figure 2 and reviewed extensively in Carpenter and Bosselut 
(Carpenter and Bosselut). 
The thymus is structured in several lobules, each containing discrete 
cortical (outer) and medullary (central) regions. As shown in figure 3, thymus-
seeding progenitors enter through blood vessels at the cortico-medullary 
junction (CMJ). Distinct thymocyte subsets occupy discrete regions of the 
thymus, indicating that differentiation is coupled with migration through the 
stroma in response to chemokine signals. Progenitors travel from the CMJ 
through the cortex to the subcapsular zone (SCZ) during the early DN stages. 
Therefore, the cortex consists mainly of immature thymocytes embedded in a 
network of branched cortical thymic epithelial cell (cTEC) and intermittent 
macrophages. In the outer cortical area, DN3 cells undergo TCR β 
rearrangement and β-selection, and the resulting immature single-positive 
(ISP) intermediate cells and then DP cells migrate back through the cortex. 
Positively selected SP thymocytes enter the medulla, where effective negative 
selection occurs. γδ and αβ T cell lineages diverge at the DN3 stage. Mature 
thymocytes surrounded by medullary thymic epithelial cell (mTEC), 
macrophages and medullary DC make up the medulla (Ciofani and Zuniga-
Pflucker, 2007). 
 
   1.2.1.1.1. Classical pathway of αβ T cell development 
 
 The majority of lymphoid progenitor cells present in the thymus follow 
the main pathway of T cell development (Fig. 3 (Ciofani and Zuniga-Pflucker, 
2007)), resulting in the generation of a repertoire of T cells that carry a unique 
TCR, consisting of an alpha and a beta chain, on their surface, and a co-
receptor molecule that can be either CD4 or CD8. 
 However, there are several branch points during early thymocyte 
development that can divert the cells into other lineages. 
 
   1.2.1.1.2. iNKT cells 
 
 The iNKT cells constitute a lymphocyte subpopulation that is abundant 
in the thymus, spleen, liver, and bone marrow and is also present in the lung. 
iNKT cells express surface markers that are characteristic of both natural killer 
cells (such as NK1.1 and CD122) and conventional T cells (such as TCRs). 
They have been implicated in the regulation of immune and autoimmune 
responses. The majority of iNKT cells utilizes a restricted TCR repertoire that 
recognizes glycolipids in association with the non-polymorphic MHC-like 
molecule CD1d. These cells carry TCRs made of a nearly invariant TCRα 
chain (Vα14Jα18 in mice) associated to a small set of TCRβ partners (Vβ8.2, Vβ7 
or Vβ2)(Carpenter and Bosselut). The development and maintenance of NKT 
cells are extensively reviewed in Godfrey et al. (Godfrey et al.). 
 


















Figure 3 : Schematic view of T lymphopoiesis within the thymus. The thymus is divided into two histologically defined 
regions, the cortex and the medulla, each of which contains specialized thymic epithelial cell (TEC) subsets. Thymus-
seeding progenitors enter through blood vessels at the cortico-medullary junction (CMJ) and undergo an ordered 
process of development. Distinct thymocyte subsets occupy discrete regions of the thymus, indicating that 
differentiation is coupled with migration through the stroma in response to chemokine signals. Progenitors travel from 
the CMJ through the cortex to the subcapsular zone (SCZ) during the early double-negative (DN) stages. Here, DN3 
cells undergo T cell receptor (TCR) β rearrangement and β-selection, and the resulting immature single-positive (ISP) 
intermediate cells and then double-positive (DP) cells migrate back through the cortex. Positively selected single- 
positive (SP) thymocytes enter the medulla, where effective negative selection occurs. γδ and αβ T cell lineages 
diverge at the DN3 stage. Developmental stages are depicted by different cell colors, black arrows indicate 
developmental progression and/or migration, and red arrows indicate outcomes leading to cell death. Daggers mark 
cell populations undergoing apoptosis or death by neglect at critical developmental checkpoints. Thymus-derived 
factors vital to the early stages of T-lymphopoiesis are denoted on or near TEC representations. The thymus is a 
bilobed organ, composed of many nodular lobules separated by a thin connective septum, shown as a gray enclosing 
structure. cTEC, cortical TEC ; ETP, early thymic progenitor ; IL-7, interleukin-7 ; mDC, medullary dendritic cell ; 




1.2.1.1.3. γδ T cells 
 
Another cell lineage, the γδ T cells, express TCRs γδ instead of TCRs 
αβ, and make up 1-5% of the T cells in the thymus. γδ T cells are also the first 
T cells that appear during embryonic mouse development. αβ T cells appear 
only a few days after the earliest γδ T cells and rapidly become the 
predominant thymocyte population (Havran and Allison, 1988). 
Following the definitive commitment to the T cell lineage in the thymus, 
T cell precursors express the IL-2 receptor α chain (CD25) and begin to 
rearrange and express their TCRδ, γ, and β genes. Cells that successfully 
rearrange TCRγ and TCRδ genes express a TCRγδ and can proceed along 
the γδ lineage pathway. Similarly, cells that successfully rearrange their TCRβ 
gene express a pre-TCR (formed by association of TCRβ with the invariant 
pTα chain) and are able to differentiate along the αβ lineage (Kang and 
Raulet, 1997). 
Current models of lineage commitment at the DN stage distinguish between 
two possible roles for the TCR : instructing commitment or reinforcing a prior 
commitment event (Hayday et al., 1999). Unlike in αβ cells, there is no ‘pre-
TCRγδ’ ; the DN3 checkpoint assesses signalling by complete TCRγδ 
complexes. Moreover, γδ lineage differentiation does not depend on Notch 
signalling. A current view for αβ versus γδ lineage commitment is that strong 
signals promote γδ lineage choice and that γδ TCR signals are stronger than 
pre-TCR signals. Nevertheless, the αβ versus γδ cell type divergence has 
been a contentious issue (Carpenter and Bosselut). 
 γδ T cells are often considered to be a more primitive cell type, since 
they are emerging earlier than αβ T cells in phylogeny and ontogeny, and 
might therefore define an interface between the innate and adaptive immune 
systems (Pennington et al., 2003). At the functional level, they effectively have 
a role as a bridge between the innate and the adaptive immune systems, 
based on the interpretation that γδ T cells use their TCR as a pattern 
recognition receptor (Holtmeier and Kabelitz, 2005). In addition, γδ T cells 
rapidly produce a variety of cytokines and usually exert potent cytotoxic 
activity, also towards many tumor cells. 
 
   1.2.1.2. T cell function 
 
 T cells are able to distinguish cells that are harboring pathogens by 
recognizing peptide fragments of pathogen-derived proteins displayed by the 
cell in a complex with the MHC molecule. There are two different classes of 
MHC, class I and II (Fig. 4 (Klein and Sato, 2000)), that are specialized in the 
presentation of peptides derived from different cellular compartments. MHC 
class I molecules present peptides from the cytosol and are recognized by 
CD8+ killer T cells, while MHC class II molecules display peptides generated 
in vesicles and are recognized by CD4+ helper T cells (Fig. 5 (Klein and Sato, 
2000)). Thus, the two different functional subsets of T cells can become 
activated and contribute to the host defense against different types of 
pathogens. On the one hand, proteins from viruses or other intracellular 










































Figure 4 : Structure of HLA Class I and Class II molecules. Beta2-microglobulin (β2m) is the light chain of the class I 
molecule. The α chain of the class I molecule has two peptide-binding domains (α1 and α2), an immunoglobulin-like 
domain (α3), the transmembrane region (TM), and the cytoplasmic tail. Each of the class II α and β chains has four 
domains : the peptide-binding domain (α1 or β1), the immunoglobulin-like domain (α2 or β2), the transmembrane 














killed by a killer T cell (CD8+ T cell) that recognizes the Ag as non-self. On the 
other hand, extracellular pathogens and toxins taken up in vesicles, usually by 
phagocytic cells such as macrophages, are presented in MHC class II 
complexes to helper T cells (CD4+ T cells) that activate B cells to secrete 
specific Abs that help to eliminate the pathogens (Kenneth M. Murphy, 
2008b).	
  
 Each individual TCR is specific for a particular MHC-peptide complex 
or, in other words, MHC-restricted for Ag recognition. Thymocytes with TCRs 
that are able to recognize self-MHC molecules and function in self-MHC-
restricted responses to foreign Ags are positively selected for survival in the 
thymus. The positive selection relies critically on cTEC that make close 
contacts with the T cells which express CD4 and CD8 co-receptors on their 
cell surface. This process depends on the engagement of both the Ag 
receptor and co-receptor with an MHC molecule, and determines the survival 
of SP cells that express only the appropriate co-receptor. Positively selected 
SP thymocytes are ready for export to the periphery. The function of the CD4 
or CD8 co-receptors of the mature T cells lies in their distinct abilities to bind 
invariant sites on MHC class II or class I molecules, respectively. 
 In the thymus, negative selection occurs to cells that encounter their 
corresponding Ag (a self-peptide) on a self-MHC of an Ag presenting cell 
(APC). The most important types of APCs are the bone marrow-derived DCs 
and macrophages. These are professional APC types that also activate 
mature T cells in peripheral lymphoid tissues. Each individual thymocyte must 
undergo negative selection in the thymus to enable the immune system to 
respond to virtually any foreign Ags but avoid harmful responses to self in the 
periphery. The education process of thymocytes could, in principle, be 
accomplished either by recognizing one or a set of « common » peptides, 
which could represent all peripheral self-Ags in the thymus, or by « seing » 
the actual peripheral, tissue-restricted or age-dependent, self-peptides 
expressed in the thymus, or by both. Discovery of the autoimmune regulator 
(Aire) gene provided the first direct evidence for the latter hypothesis (Jiang 
and Chess, 2009). 
 Once they have completed their development in the thymus, T cells 
enter the bloodstream and are carried by the circulation. On reaching a 
peripheral lymphoid organ, they leave the blood to migrate through the 
lymphoid tissue, returning again to the bloodstream to recirculate between 
blood and peripheral lymphoid tissue until they encounter their specific Ag. 
 The activation of naive T cells in response to Ag, and their subsequent 
proliferation and differentiation, constitutes a primary immune response. At 
the same time as providing armed effector T cells, this response generates 
immunological memory, which gives protection from subsequent challenge by 
the same pathogen. The generation of memory long-lived T cells that give an 
accelerated response to Ag and the generation of effector T cells present 
similarities and differences (reviewed in Seder and Ahmed (Seder and 
Ahmed, 2003)). Memory T cells differ in several ways from naive T cells, but 
like naive T cells, they are quiescent and require activation by APCs with co-
























































Figure 5 : Antigen processing. Panel A shows the principal pathways of generating peptides for loading onto HLA 
class I molecules. Worn-out or defective proteins in the cytosol are degraded into peptides in proteasomes. Selected 
peptides are then transported into the endoplasmic reticulum, where they are loaded onto newly synthesized class I 
molecules. The HLA-peptide complexes are exported by way of the Golgi apparatus to the surface of the cell. In 
tissues infected with a virus, viral particles are taken up by cells and uncoated. The viral DNA or RNA enters the 
nucleus and replicates within it. The viral messenger (mRNA) then enters the cytosol and is transcribed into proteins. 
Some of the proteins are subsequently degraded in proteasomes, and the peptides are delivered into the 
endoplasmic reticulum, where they are loaded onto class I molecules for export to the surface of the cell. Panel B 
shows the processing of extracellular proteins. Self or foreign proteins are taken up by endocytosis (or phagocytosis) 
and sequestered into endosomes. Class II molecules synthesized in the endoplasmic reticulum are delivered by way 
of the Golgi apparatus into primary lysosomes, which fuse with the early endosomes to form the major-
histocompatibility-complex (MHC) class II compartment. Enzymes brought into this compartment by the lysosomes 
degrade the engulfed proteins into peptides. HLA-DM molecules synthesized in the endoplasmic reticulum and 
delivered into the MHC class II compartment by transport vesicles help load the peptides onto the class II molecules. 







 1.2.2.1. Main stages of B cell development in the bone 
marrow and spleen 
 
The bone marrow is the site of early events in B cell maturation. 
Indeed, in the bone marrow, B lymphocytes go through successive stages of 
differentiation : the Pro B cell (B cell Progenitor), the Pre B cell (B cell 
Precursor) and the immature B cell. They become mature B cells in the 
spleen. 
The spleen is the major site of immune responses to blood-borne Ags. 
The lymphocyte-rich regions of the spleen, called the white pulp, are 
organized around branches of central arteries (Fig. 6 (Mebius and Kraal, 
2005)). The architecture of the white pulp is analogous to the organization of 
lymph nodes, with segregated T and B cell zones. In mouse spleen, the 
central arteries are surrounded by cuffs of lymphocytes, most of which are T 
cells. Because of their anatomic location, morphologists call these T cell 
zones periarteriolar lymphoid sheaths (PALS). Several smaller branches of 
each central arteriole pass through the PALSs and drain into a vascular sinus. 
B cell-rich follicles occupy the space between the periarteriolar sheath and the 
marginal sinus. Outside the marginal sinus is a distinct region called the 
marginal zone (MZ), which forms the outer boundary of the white pulp and is 
populated by B cells and specialized macrophages. The B cells in the MZ are 
functionally distinct from follicular B cells and are known as marginal zone B 
(MZ B) cells. The segregation of T lymphocytes in the PALSs, and B cells in 
follicles and MZs is a highly regulated process, dependent on the production 
of different cytokines and chemokines by the stromal cells in these different 
areas. 
Some of the arteriolar branches of the splenic artery ultimately end in 
extensive vascular sinusoids, distinct from the marginal sinuses, scattered 
among which are large numbers of erythrocytes, macrophages, DCs, sparse 
lymphocytes and plasma cells ; these constitute the red pulp. The plasma 
cells, generated in peripheral lymphoid tissues as a consequence of antigenic 
stimulation of B cells migrate to the bone marrow, where they may live and 
continue to produce Abs for many years (Abul K. Abbas, 2010). 
 
  1.2.2.1.1. Development of immature B cells in the bone 
marrow 
 
Just like the aforementioned T lymphocytes, B cells arise from 
pluripotent progenitors in the fetal liver or in the bone marrow of adult mice. 
They start their maturation in these tissues and complete it in the secondary 
lymphoid organs, such as the spleen and the lymph nodes. Commitment to 
the B cell lineage is followed by rearrangement and expression of the B cell 
receptor genes : the Ig heavy and light chain genes. The process of B cell 
differentiation involves first the rearrangement of the Ig heavy chain genes 
(Igh), followed by a burst of proliferative clonal expansion (as a consequence 
of signalling through the Pre B Cell Receptor or Pre-BCR), and then, the 
rearrangement of the Ig light chain loci at the Pre B cell stage. The Pre-BCR 






















Figure 6 : Structure of the spleen. The afferent splenic artery branches into central arterioles, which are sheathed by 
white-pulp areas ; these white-pulp areas consist of the T-cell zone (also known as the periarteriolar lymphoid 
sheath, PALS), arterioles and B-cell follicles. The arterioles end in cords in the red pulp, from where the blood runs 
into venous sinuses, which collect into the efferent splenic vein. The larger arteries and veins run together in 
connective-tissue trabeculae, which are continuous with the capsule that surrounds the spleen. Adapted from Mebius 
















Successful pairing of one of the κ or λ light chains with the heavy chain 
results in surface expression of Immunoglobulin M (IgM), the hallmark of 
immature B cell stage, at which cells are checked for auto-reactivity. Upon 
encounter with autoantigens that are recognized by this sIgM, the cells can 
downregulate the IgM surface expression and induce a further rearrangement 
of the Ig light chain gene by a process termed receptor editing. Cells that 
remain autoreactive undergo programmed cell death (apoptosis), but those 
that lose the autoreactivity through receptor editing can proceed normally in 
their development. IgM-expressing cells that were not negatively selected for 
recognition of self molecules can subsequently exit the bone marrow and 
complete their maturation in the spleen. Discrete stages of B cell development 
have been defined based on : 
- the cell cycle status and cell size 
- the status of Ig heavy (H) and light (L) chain rearrangement 
- the expression of several products of genes on the cell membrane or 
in the cytoplasm (especially those of the rearrangement machinery : Rag-1, 
Rag-2, TdT and the Pre-BCR and BCR complex : IgH chain, (surrogate) IgL 
chain, Igα and Igβ chains). Figure 7 depicts these successive stages of Ag 
independent B cell development. In addition, it indicates the stages at which 
various transcription factors have been found to be important, usually on the 
basis of knockout studies. 
 
1.2.2.1.2. T cell dependent (TD) immune responses 
 
Immature B cells enter the spleen from the blood at the level of the MZ 
where they can be further checked for self-reactivity in the periphery and 
consequently enter an anergic state ; alternatively, they can mature further 
into terminally differentiated plasma cells. B cells that have freshly entered the 
spleen can be identified by their cell surface reaction with the monoclonal Ab 
493 (Rolink et al., 1998), which presumably recognizes the cell surface 
marker AA4.1, which is the complement component C1q like receptor C1qRp 
(Rolink et al., 2002). Subsequently, the (naive) B cells cross the marginal 
sinus and migrate via the PALS to the lymphoid follicles, which are areas 
specialized in Ag retention and presentation. Upon encounter with T cell 
dependent Ag, such mature IgM+IgD+ B cells become activated and proliferate 
with T cell help. The T helper cells (Th) required for this activation are 
CD4+CD8- cells that can be divided into two subpopulations according to their 
cytokine profile : activated Th1 cells secrete mainly IL-2 and IFN-γ, while 
activated Th2 cells secrete IL-4 and IL-5. Th cell get activated by binding of 
Ag processed and displayed by APCs. Upon activation, Th cells upregulate 
the expression of a number of accessory receptors and ligands (e.g. CD40L 
and CD28) that are essential for B cell activation in TD immune responses. 
The activated mature B cells then differentiate predominantly into low affinity 
Ab-forming cells (AFCs), which are short-lived plasmocytes that initially 
secrete IgM, but subsequently switch to secondary isotypes and die by 
apoptosis within two weeks of immunization. Some cells from the expanded B 
cell pool do not become AFCs but migrate into the adjacent follicles, which 
are subsequently transformed into germinal centers (GCs). GC B cells 
undergo iterative cycles of proliferation, somatic hypermutation and apoptosis 

























Figure 7 : Murine B cell development. Discrete stages of B cell development, based on cell size, on the 
rearrangement status of the immunoglobulin genes and the expression of genes on the cell membrane or in the 
cytoplasm, are shown. Immature B cells are depicted overlapping the bone marrow and the spleen because these 
cells are present in both organs. Some epigenetic and transcription factors identified to be crucial for B cell 


















resulting in the selection of B cell clones that make an Ab with high affinity for 
a cognate Ag. Additionally, Ig class switching occurs during the GC reaction. 
These steps expand, refine and diversify the repertoire of the early immune 
response to assure the long-term maintenance of protective immunity. Two 
types of terminally differentiated B cells eventually emerge from the GC 
reaction : nonsecreting, Ig surface-positive memory B cells and high affinity 
Ab-secreting plasmablasts that carry no Igs at their surface and that are the 
final mediators of the humoral immune response. Figure 8 (Oracki et al.) gives 
an overview over the B cell fate in the spleen. 
 
1.2.2.1.3. T cell independent (TI) immune responses 
 
 As we have seen in the previous section, Ags recognized by the BCR 
usually require costimulatory signals from helper T cells to elicit a specific 
(TD) immune response. Some Ags however, including mostly bacterial cell 
wall components, such as LPS and certain sugars (e.g. Ficoll), can stimulate 
the B cells by themselves to proliferate and to secrete Abs independently of T 
cell help. These TI Ags do not lead to the formation of immunological memory, 
and the Abs that arise from a TI immune response usually do not undergo 
affinity maturation or class switching. The B cell subsets that are required for 
TI immune responses are preactivated splenic MZ B cells, as well as B-1 B 
cells which provide a bridge between the very early innate and the later 
appearing adaptive immune response by generating an initial wave of IgM 
producing plasmablasts during the first three days of a primary response to 
particulate bacterial Ags (Martin and Kearney, 2000; Martin et al., 2001). 
 
    1.2.2.1.3.1. B-1 B cells 
 
 B-1 cells constitute a subset of B cells that are dominant in the 
peritoneal and pleural cavities. Their precursors develop in the fetal liver and 
omentum. In adult mice, lymphoid organs contain precursors that can develop 
into B-1 cells when they express the appropriate BCR specificity and/or 
signalling threshold (Duan and Morel, 2006). B-1 cells recognize self 
components, as well as common bacterial Ags, and they secrete natural Abs 
important for innate immunity that tend to have low affinity and broad 
specificity - mostly self-reactive antibodies - (Mayer and Zaghouani, 1991; 
Shirai et al., 1991; Welner et al., 2008). B-1 cells make Ab responses mainly 
to polysaccharide Ags in a TI manner. They can be distinguished from the 
conventional B-2 B cells - which originate from bone marrow and are 
distributed to mucosal and systemic immune compartments for the continuous 
secretion of Abs with high affinity and fine specificity -, by their self-renewing 
capacity, which allows their size population to be kept constant and unique 
cell surface proteins. In contrast to other B cell populations, they are B220lo, 
IgMhiIgDloCD23-CD43+MAC1+. The B-1a cell subset expresses CD5, but is 
otherwise almost indistinguishable from the B-1b cells (Kantor et al., 1992; 


















































Figure 8 : Architecture of the splenic white pulp. The white pulp comprises a T cell area, called the periarteriolar 
lymphoid sheath (PALS), surrounding a central arteriole. Adjoining this are the follicles, which are home to the 
majority of naive B cells and are enveloped by the marginal zone (MZ). Partitioning of these areas is based on 
differential expression of the chemokines CXCL13 in the B cell follicle, CCL19 and CCL21 in the PALS, and CXCR4 
in the red pulp. Antigen entering through blood can activate MZ B cells, causing their migration toward the PALS and 
subsequent migration, proliferation and differentiation to short-lived plasma cells in extra-follicular foci. Follicular B 
cells activated by antigen also traffic to the boundary of the T cell zone. From here, these cells may continue their 














1.2.2.1.3.2. MZ B cells 
 
 MZ B cells consist mainly of a large, mostly non-circulating subset of 
mature B cells that are localized in the MZ of the spleen. As mentioned 
before, they have an important function at the early stages of the immune 
response. This could be attributed to their observed lower activation threshold 
that triggers them more easily into proliferation or differentiation than 
immature or recirculating mature B cells. 
 A number of genes that are crucial for the generation or maintenance 
of the MZ B cell compartment have been identified by targeted disruption or 
overexpression studies. There are four broad categories of mutations in mice 
that result in defects in MZ B cells : mutations involving negative regulators of 
the BCR that result in enhanced BCR signalling ; mutations involving the 
BAFFR (B cell activating factor receptor) and the canonical NF-κB (Nuclear 
Factor-kappaB) pathway ; mutations in the Notch pathway ; and mutations 
involving signalling molecules that are linked to integrin or chemokine 
activation, which might be required for the post-migration retention of MZ B 
cells in the MZ. 
Interestingly, in Aiolos-deficient mice, in which the strength of BCR 
signalling is increased, the numbers of splenic IgMhiIgDloCD23-CD21hiCD1dhi 
MZ B cells were markedly decreased. The number of 
IgMhiIgDhiCD23+CD21hiCD1dhi B cells, which are now recognized as MZ 
precursor B cells, was also markedly decreased in these mice (Cariappa et 
al., 2001). This indicates that increased BCR signalling decreased the 
differentiation of maturing B cells into MZ B cells. 
Otherwise, BAFF is a trimeric member of the tumour necrosis factor 
family, required for marginal B cell development (Batten et al., 2000; 
Schiemann et al., 2001). In addition, constitutively active IKKβ (Inhibitor of 
nuclear factor kappa-B kinase subunit beta, a component of the canonical NF-
κB pathway) can correct the phenotype of BAFFR-deficient mice, resulting in 
the rescue of both follicular B cells and MZ B cells. 
In addition, the requirement for Notch2 for the generation of both 
precursor and mature MZ B cells has led to some intriguing insights about the 
follicular versus MZ B cell transition. In the Notch signalling pathway, 
intracellular Notch, RBP-Jκ (recombination signal binding protein for 
immunoglobulin kappa J region) and Mastermind proteins form a ternary 
complex that activates Notch target genes. Knockout mice lacking Notch2 or 
RBP-Jκ in B cells, Mastermind-like 1 (MAML1) or the Notch ligand DL1 all 
have defects in MZ B cell development (Hozumi et al., 2004; Saito et al., 
2003; Tanigaki et al., 2002; Wu et al., 2007). 
Clearly, signals for commitment to a MZ B cell fate (through the BCR, 
the canonical NF-κB pathway and Notch2) dictate the acquisition of the ability 
of the committed cell to migrate, differentiate further, self-renew and be 
retained in the MZ. Several molecules contribute to the migration and/or 
retention of MZ B cells in the spleen. For instance, the sphingosine 1-
phosphate receptor (S1PR1) participates in MZ B cell migration and retention 
in vivo and is crucial to overcome CXC-chemokine ligand 13 (CXCL13)-
mediated attraction of B cells to the follicles (Cinamon et al., 2004). 
Otherwise, a mutation in the Pik2 (also known as Ptk2b) gene, which encodes 

















































Figure 9 : Commitment to a marginal zone B cell fate. Although weak BCR signalling is the initial event driving 
commitment, acquisition of the marginal zone B cell phenotype also requires further signalling pathways. Signals 
resulting from the interaction of delta-like 1 (DL1) expressed by endothelial cells of red pulp venules with Notch2 on 
developing B cells lead to activation of the transcription factors Mastermind-like 1 (MAML1) and RBP-Jκ. Signals 
resulting from the interaction of BAFF with BAFFR activate NF-κB through the canonical pathway. A Gα12- or Gα13-
coupled serpentine receptor, probably the sphingosine 1-phosphate receptor (S1PR1), and integrin signalling 
contribute to the processes of migration to and retention in the marginal zone, although the identity of the 











absence of MZ B cells (Guinamard et al., 2000). In addition, there are certain 
mutations in genes also linked to integrin signalling that might have effects 
downstream of the BCR. The OBF-1 transcriptional coactivator lies 
downstream of the BCR but might also be required for the migration of B cells 
as the number of MZ B cells is decreased in the absence of OBF-1. However, 
the exact role of OBF-1 in B cell migration is not fully understood (Samardzic 
et al., 2002). Figure 9 summarizes the signals required for commitment to a 
marginal B cell fate (Pillai and Cariappa, 2009). 
 
  1.2.2.2. B cell function 
 
The expression of Igs, either as cell surface receptors, or in secreted 
form as Ab molecules, is a unique feature of B cells. An Ig molecule consists 
of two identical set of heavy (H) and light (L) polypeptide chains held together 
by a combination of noncovalent bonds and covalent disulfide bonds (Fig. 10 
(Kazatchkine and Kaveri, 2001)). Each polypeptide chain features one 
variable (V) and one constant (C) domain. The Ag is bound by both the VH 
and VL domains. The V region can be further divided into hypervariable 
regions, also called complementarity determining regions (CDRs), and more 
conserved framework regions (FR). The C region is characteristic for each 
distinct isotype group. There are five isotypes or main H chain classes, some 
of which have several subtypes : IgM, IgD, IgG, IgA and IgE. Abs of different 
isotypes operate in distinct functional activities. The corresponding H chains 
are denoted µ, δ, γ, α and ε, respectively. Initially, all immature B cells express 
the IgM isotype and may switch to a different isotype at later stages of B cell 
maturation. 
 
  1.2.2.2.1. Organization and transcription of the Ig loci 
 
The functional gene segments that make up the Ig H and L chains are 
organized into three clusters, located on different chromosomes : the H chain 
genes, and the κ and λ L chain genes. Multiple copies of all of these gene 
segments exist in germline DNA (Fig. 11 (Schatz and Ji)). The two loci of L 
chain genes, κ and λ, are alternatively used, with species-specific preferences 
(κ to λ ratios of 2:1 in man and 20:1 in mouse), but apparently without 
functional differences. 
In order to form the functional Ig molecules, the gene segments have to 
be assembled by somatic recombination. Two types of recombinatorial events 
take place at the Ig locus during B cell development : V(D)J recombination at 
both H and L loci, and class switch recombination (CSR) at the H locus. 
 
1.2.2.2.1.1. V(D)J recombination, class switch 
recombination and recombination machinery 
 
During the process of V(D)J recombination, the H chain rearrangement 
occurs first, starting with a rearrangement joining one of the DH gene 
segments with one of the JH gene segments. Subsequently, one VH gene 
segment is joined to shape a VDJ-CH gene. Rearrangement of the L chain 
follows, where one of the VL gene segments is directly joined to a JL gene 















































Figure 10 : The IgG molecule. The site of interactions between IgG and antigen (epitope) is shown, as are binding 
sites for C1q and activated C3b and C4b and sites of interaction between the heavy (H) chains of IgG and Fcγ 
receptor types I, II, and III. V denotes variable region, C constant region, and L light chain. Note that VH and VL 














transcription joins the V(D)J segments to the closest downstream C region 
coding sequence. In immature B cells, this is Cµ or, if alternative splicing 
occurs during late phases of B cell development, Cδ. The C genes are 
organized in the following order in the mouse genome : 5’-V(D)J-Cµ-Cδ-Cγ3-
Cγ1-Cγ2b-Cγ2a-Cε-Cα-3’ (D'Eustachio et al., 1980). 
The second type of recombinatorial event occuring at the Ig locus 
during B cell development is the CSR at the IgH locus. CSR is a deletional 
process that places a C gene other than Cµ or Cδ directly downstream of the 
rearranged VDJ segments, leading to the expression of other secondary Ig 
isotypes encoded by downstream C genes, such as IgG, IgA and IgE 
(Stavnezer, 1996). CSR occurs between highly repetitive G-rich switch (S) 
sequences with abundant palindromes that precede every C region, except 
for Cδ. This process is controlled by a serie of signals involving BCR and 
cytokine signalling, and in which B cell - T cell interactions play a critical role. 
The activation and targeting of CSR correlates with the capability of certain 
mitogens and cytokines to either induce or suppress germline transcription of 
specific C genes (Manis et al., 2002; Snapper et al., 1997). 
Both recombinatorial events are thus intimately linked to transcription 
of the locus. 
In both V(D)J rearrangements and CSR, chromosomal DNA double-
strand breaks (DSB) are generated and differentially re-ligated, thereby 
deleting the interjacent genomic sequence. In the case of V(D)J 
rearrangements, this relies on highly conserved recombination signal 
sequences (RSS), short stretches of DNA present 3’ of each V region, 5’ and 
3’ of D regions and 5’ of each J region. RSS always consist of a conserved 
heptamer and nonamer elements separated by a less well conserved spacer 
region of either 12 or 23 base pairs, which defines the 12RSS and 23RSS, 
respectively. V(D)J rearrangements occur only between gene segments 
located on the same chromosome and follow the 12-23 rule, a restriction due 
to a strong preference for recombination between a segment flanked by a 
12mer-spaced RSS to one with a 23mer-spaced RSS. As both VH and JH 
segments are flanked by 23 bp spacers and the DH segments are flanked by 
12 bp spacers, only DH to JH segment joining and VH to DH segment joining 
are possible ; VH to JH segment joining is not possible (Eastman et al., 1996; 
Tonegawa, 1983). 
V(D)J recombination is initiated by the RAG recombinase (referred to 
hereafter as RAG) – a protein complex consisting primarily of the proteins 
encoded by recombination activating gene 1 (Rag-1) and Rag-2 -. RAG binds 
and cleaves the DNA at RSSs ; it catalyzes both the DSB and re-ligation 
reactions. DNA repair during V(D)J recombination is channelled into the non-
homologous end joining (NHEJ) pathway by the RAG proteins. RAG1 is able 
to interact with the NHEJ factors Ku70 (also known as XRCC6) and Ku80 
(also known as XRCC5) (Schatz and Ji). Ku70 and Ku80 form a complex with 
the DNA-dependent protein kinase catalytic subunit to form the full DNA-
dependent protein kinase (DNA-PK). 
Isotype switch recombination also requires DNA-PK, but can occur in 






























Figure 11 : The structure of antigen receptor genes. Schematic diagrams of the four mouse antigen receptor loci for 
which the binding patterns of the recombination activating gene (RAG) proteins have been reported. Variable (V), 
diversity (D) and joining (J) gene segments are represented as yellow, red and blue rectangles, respectively, 
constant (C) regions are shown as purple rectangles, enhancer elements as green ovals and germline promoters 
associated with recombination centres as green diamonds with arrows. The promoters associated with each V gene 
segment and the recombination signal sequences (RSSs) are not shown. The approximate sizes of the regions within 
each locus are indicated, together with the approximate number of gene segments in each region (shown in 
parentheses). The recombination centres (blue shaded areas) are the regions that are bound by RAG1 and RAG2 
when the loci are in their germline configurations. From top to bottom, the immunoglobulin heavy chain (Igh) locus in 
its germline and assembled configurations, the germline Igk locus, the germline T cell receptor β-chain (Tcrb) locus, 
the germline Tcra-Tcrd locus. The Tcra recombination centre is represented by two triangles to depict the 5’ to 3’ 
gradient of RAG binding observed downstream of the T early α (TEA) element and the increase observed 









1.2.2.2.1.2. Sterile and productive transcripts 
 
Two types of Ig transcripts are expressed during B cell development : 
sterile germline and productive transcripts. Sterile transcripts result from Ig 
gene transcription preceding gene rearrangement and class switching and are 
not translated. It is generally believed that sterile transcripts alter the 
accessibility of the Ig loci and thereby influence the regulation of gene 
rearrangements. Sterile transcripts have been characterized from most of the 
CH genes, as well as for Cκ and Cλ L chain genes. 
Productive transcripts originate from the transcription of rearranged Ig 
genes and are translated into functional proteins. 
 
   1.2.2.2.1.3. Affinity maturation and AID 
 
The efficiency of Ag elimination is also enhanced by affinity maturation, 
which is accomplished by a high number of point mutations in the V-region 
gene, coupled with selection of high-affinity APCs by limited amounts of Ag. 
Point mutations are introduced by two types of molecular mechanisms : non-
templated somatic hypermutation (SHM) and gene conversion (Reynaud et 
al., 2003). The process of SHM can be divided into three phases : targeting, 
DNA recognition and cleavage, and repair. The first phase of targeting a 
nuclease to the Ig locus necessitates transcription (Jacobs and Bross, 2001). 
While some sequence specificity was reported, it remains unclear what is 
recognized by this nuclease (Michael et al., 2002). The cleavage mediated by 
the nuclease is part of the second phase leading to a DNA DSB (Bross et al., 
2000; Papavasiliou and Schatz, 2000), which might be preceded by a single 
strand lesion (Kong and Maizels, 2001). In the final phase, the DSB is 
probably repaired into a mutation by a subset of error-prone polymerases 
(Gearhart and Wood, 2001; Papavasiliou and Schatz, 2002). 
The activation-induced deaminase (AID) is an enzyme specifically 
expressed in GC B cells, which is required for CSR, SHM and gene 
conversion. The analyses of several AID mutants indicate a requirement for 
class-switch-specific cofactors. Nevertheless, the exact function of AID is still 
a matter of considerable debate. Two mechanisms : RNA-editing and DNA-
deamination have been suggested and extensively reviewed in Honjo et al. 
(Honjo et al., 2005). A model integrating AID-dependent mechanisms that 
diversify Ig genes in SHM, gene conversion and CSR pathways is shown in 
figure 12 (Papavasiliou and Schatz, 2002). 
 
   1.2.2.2.1.4. Allelic exclusion, receptor editing 
 
For each Ig locus, there are two alleles that can undergo gene 
rearrangement, and this increases the chance of a successful event. After the 
first allele has successfully rearranged, the recombination machinery is 
quickly downregulated, so that generally only one correctly rearranged IgH 
and IgL locus is found in any B cell. This phenomenon is called allelic 
exclusion. The other allele remains in germline configuration, is partially 
rearranged or has completed an unproductive recombination. 
Another rescue mechanism that prevents excessive unproductive 























    
 
 
Figure 12 : AID-dependent mechanisms that diversify Ig genes. A. Schematic diagram of the Ig heavy chain locus, 
with the variable (VDJ) and constant (C) region exons represented as blue and gray rectangles, respectively, switch 
regions as red and green ovals, and promoter (P), enhancer (E), and 3’ regulatory regions (3’RR) regions as black 
circles. Not to scale. B. Somatic hypermutation causes point mutations (x) in the vicinity of the V exon. Thin arrows 
represent transcription in B, C, and D. C. Gene conversion involves the transfer of sequence information from a 
pseudogene (ψV) into the variable region exon. D. Class switch recombination involves looping out and deletion of 
DNA between two switch regions (in this case Sµ and Sε), thereby swapping the constant region of the expressed 

















avidity is the process of receptor editing. Unlike the H chain genes, repeated L 
chain gene rearrangements of unused V and J gene segments can occur, 
thereby leading to production of a new IgL chain and increasing the chance of 
the B cell precursors to generate progeny (the immature B cells) that bears 
intact IgM molecules. 
    
The entire sequencing of the human genome has revealed that it was 
composed of a surprisingly small number of genes. Among them, only a 
limited number were encoding the V, D, and J regions ; which was not 
sufficient to explain the 109 clones of mature lymphocytes of the human 
organism. Indeed, several sophisticated mechanisms are existing in mammals 
so as to generate the diversity of the Ab repertoire. Many V region gene 
segments exist in the genome of an individual, providing a hereditable source 
of diversity. Random recombination of separate V, D, and J gene segments 
during V(D)J recombination provide additional diversity. Variability of the 
junctions between the gene segments is increased by the random insertion of 
P- and N-nucleotides and by deletion of nucleotides at the ends of some 
coding sequences. The association of different L and H chain V regions adds 
diversity. For increasing the diversity of the Ag-binding site, in the periphery, 
mature B lymphocytes undergo additional DNA alterations induced by Ag 
stimulation. In the periphery, activated B lymphocytes proliferate vigorously in 
GCs of lymphoid follicles, in which two different types of genetic alterations, 
SHM and CSR take place. 
 
  1.2.2.2.2. Generation of memory B and plasma cells 
 
Iterative cycles of proliferation, SHM and apoptosis in the GC result in 
the selection of B cells that make an Ab with high affinity for cognate Ag. In 
addition, CSR occurs during the GC reaction which usually peaks ∼ 10-12 
days after immunization, giving rise to two types of B cells : non-secreting 
memory B cells that are Ig surface-positive and Ab-secreting plasmablasts. 
Plasmablasts leave the GC and develop into terminally differentiated plasma 
cells that secrete high affinity Abs (Calame, 2001). 
 
As precised above, in haematopoiesis, more than ten lineages of 
mature blood cells are derived from HSCs. This process is tightly regulated by 
extrinsic environmental cues and an intrinsic genetic program. The 
establishment of the lineage-specific gene expression patterns underlying 
differentiation is believed to be driven by the interplay of intricate networks of 
transcription factors and chromatin regulators. 
 
2. The transcriptional and epigenetic networks 
 
2.1. The transcription 
 
Eukaryotic gene transcription constitutes the basis of the most common 
and most immediate point of regulation of gene expression in a cell. 
Transcription of the eukaryotic genes is performed by three RNA 
polymerases : RNA polymerase I (Pol I) synthesizes the large ribosomal RNA 




We will focus here on Pol II transcription ; Pol I and Pol III transcription is 
reviewed in Paule and White (Paule and White, 2000). 
 
 2.1.1. Pol II transcription 
 
2.1.1.1. The basal transcription machinery 
 
 Synthesis of mRNA by RNA polymerase II (Pol II) is governed by two 
distinct DNA elements : a core promoter and upstream – or downstream – 
enhancer sequences. The core promoter determines the transcription start 
site (TSS) and directs the assembly of the pre-initiation complex (PIC), which 
consists of Pol II and general transcription factors (GTFs), namely TFIIA, 
TFIIB, TFIID, TFIIE, TFIIF and TFIIH. TFIID itself is a multi-protein complex 
containing the TATA-binding protein (TBP) and a set of TBP-associated 
factors (TAFns), which have sequence-specific DNA-binding activity and are 
involved in promoter selectivity (Burley and Roeder, 1996). 
 The core promoter often contains a TATA box, an AT-rich motif located 
25-30 bp upstream of the TSS which is bound by TBP. Another common 
element is the initiator (Inr), which encompasses the TSS and which serves 
as a binding site for additional regulatory factors. The sequence elements of a 
typical core promoter and a model of the Pol II transcription initiation 
machinery are depicted in figure 13 (Baumann et al.; Hochheimer and Tjian, 
2003). 
 The largest subunit of Pol II contains a highly conserved C-terminal 
domain (CTD) consisting of tandem repeats of the heptapeptide YSPTSPS, 
which can be differentially phosphorylated during the different stages of 
transcription. During the initiation of transcription, the CTD is 
unphosphorylated and binds to the large SRB/Mediator complex. At the 
transition to transcription elongation, the CTD becomes phosphorylated and 
Pol II dissociates from the SRB/Mediator complex and recruits the elongator 
complex as well as several pre-mRNA processing factors. The cell cycle-
specific regulation of Pol II activity also depends on the phosphorylation of its 
CTD. 
 
2.1.1.2. Transcription factors 
 
 To achieve a specific and controlled regulation of gene transcription, 
the basal transcription machinery interacts with additional proteins so-called 
transcription factors that bind to the promoter or enhancer regions. They are 
specialized nuclear proteins with the ability to bind to DNA via a sequence-
specific DNA-binding domain ; they are additionally defined by at least an 
independent regulatory domain that can either transactivate or corepress. 
Factors that do not feature a DNA-binding domain but are recruited by 
transcription factors to the active site of transcription and thereby modulate 
transcriptional activity are termed transcriptional cofactors (coactivators or 
corepressors). 
 There are various ways in which transcription factors regulate 
transcription. First, they can interact with components of the basal 
transcription machinery and thereby modulate the assembly of the PIC 




transcription factors are transcription elongation and re-initiation. They can 
also recruit chromatin modifying activities that modulate the acetylation state 
of the local chromatin and thereby can facilitate or inhibit transcription. 
Moreover, transcription factors could be involved in targeting active 
promoters to regions in the nucleus with high transcriptional activities. 
Alternatively, supporting the model of nucleus organizers, they could 
selectively recruit repressed genes to silent domains (Brown et al., 1997). 
 
  2.1.2. Transcriptional regulation of B cell development 
 
 The development, maturation and selection of mammalian B cells is a 
complex and strictly regulated process. As we have described previously, the 
successive stages of B cell differentiation can be characterized by sequential 
rearrangement of the Ig genes, and by the ordered appearance or 
disappearance of proteins at the cell surface, or within the cell (Rolink and 
Melchers, 1993). The entire program of differentiation involves not only the 
expression of B cell lineage-specific genes but, also and importantly, the 
silencing of lineage-inappropriate genes. The correct temporal establishment 
of this lineage-specific expression pattern is notably determined by the action 
of lineage-restricted transcriptional regulators. Experiments using targeted 
gene disruptions have shown that the loss of some transcription factors, such 
as PU.1 and Ikaros, affects multiple haematopoietic lineages 
(Nichogiannopoulou et al., 1998; Scott et al., 1994), whereas the loss of other 
transcriptional regulators specifically affects early B cell development. 
Remarkably, three transcription factors E2A, EBF (early B cell factor) and 
PAX-5 (paired box protein 5) have been identified to be crucial for early B cell 
development (Bain et al., 1994; Lin and Grosschedl, 1995; Nutt et al., 1999; 
Sun, 1994; Zhuang et al., 1994) by regulating notably the B cell specific gene 
that encodes the Igα subunit (mb-1) of the BCR (Sigvardsson et al., 2002). 
Yin Yang 1 (YY1), which is a zinc-finger protein that functions as a 
transcriptional activator, repressor or transcription-initiator element-binding 
protein, depending on the promoter context, is another critical regulator of B 
cell development : its specific deletion in mouse B cells causes a defect in Igh 
rearrangement and a block at the Pro B to Pre B cell transition (Liu et al., 
2007). Besides, the zinc-finger transcription factors Ikaros and Aiolos can 
activate or repress target genes by recruiting chromatin remodeling 
complexes (nucleosome remodeling and deacetylase complex, NuRD) or 
corepressors (C-terminal binding protein, CtBP) and are essential for the 
development of CLPs and mature B cells, respectively (Cariappa et al., 2001; 
Kim et al., 1999; Koipally et al., 1999). Recently, the involvement of CtBP in 
Bcl-6 autoregulation has been demonstrated (Mendez et al., 2008). This is of 
particular interest since Bcl-6 has homology with zinc finger transcription 
factors and is required for the formation of GCs –a microenvironment where 
TD Ag responses occur-. 
 
2.1.3. Immunoglobulin and surrogate light chain genes 
transcription 
 
 Like the globin genes, the Ig genes were among the first genes studied 



























































Figure 13 : Top panel. Core promoter elements. This diagram shows common core promoter elements with their 
consensus sequences (degenerate nucleotides according to IUPAC code) and relative position to the transcription 
start site (+1). The core promoter can show considerable variability as there are no universal elements. Each of the 
motifs is found in only a fraction of core promoters with different combinations. The TATA box, Initiator (Inr), 
downstream promoter element (DPE), and downstream core element (DCE) are recognition sites for binding of 
TFIID, whereas TFIIB recognition element upstream, BREu and downstream BREd interact with TFIIB. Bottom panel. 
The transcription apparatus, a multilayered ensemble of multisubunit complexes. The transcription machinery is 
responsible for the decoding and expression of genes in a regulatory network composed of various co-regulatory 
complexes that are interconnected to control RNA synthesis from a given promoter. This includes covalent 
modifications of histone tails and DNA that can influence whether a chromatin template is programmed to be 
transcriptionally active or silent. Chromatin remodeling activities catalyze the ATP-dependent deposition, removal, or 
sliding of nucleosomes to create a DNA template that is accessible to transcription factors. Activated transcription is 
controlled by co-regulatory co-activator complexes that mediate activation of transcription by activators located in a 
promoter proximal position (PA) or many kilobases away in a promoter distal position (DA). Also, the composition and 
sequence of the core promoter directs the formation of the preinitiation complex (PIC) and defines the start site of 
transcription. This involves the interplay of basal transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH) 
and RNA polymerase with distinct core promoter elements like TATA box (TATA), Inr, and DPE to position the PIC. 




described transcriptional units in this model and, therefore, constitute a very 
useful tool to analyze the regulation of gene transcription in cells. Ig gene 
transcription is a highly regulated process driven by a number of ubiquitous 
and tissue-specific transcription factors that bind to regulatory regions in the Ig 
locus. These control regions include the V gene proximal promoters and 
promoters used for sterile transcription of the H and L chain loci, the intronic 
enhancers in the J-C region of the H and κ chain loci (Eµ, iEκ), the silencers 
located near the intronic enhancers, and the 3’ enhancers of the Cα, κ and λ 
C region genes (3’EH, 3’Eκ and 3’Eλ). Additional regulatory elements are the 
matrix attachment regions (MARs), flanking the Eµ and iEκ intronic 
enhancers. Most of the control elements are depicted in figure 11 (Schatz and 
Ji). 
 The Ig surrogate light chain genes Igll1 and VpreB, while not required 
for early B cell differentiation, are also expressed in a lineage-specific manner 
to form a Pre-BCR signalling complex with µ heavy chain. Thus, the Igll1 and 
VpreB loci are a model system for studying gene regulation during early B cell 
development. 
 
   2.1.3.1. V region promoters of Ig genes 
  
 The V region promoters contain several control elements, the most 
highly conserved elements being a TATA box about 25 bp upstream of the 
transcription start site and an octamer element (ATGCAAAT) or its reverse 
complement. This element is also conserved in some Ig enhancers and in the 
promoters of other B cell specific genes. Other consensus elements in many 
V promoters and enhancers include CAAT enhancer binding protein (C/EBP) 
binding sites and µE3 elements, which are binding sites for E box proteins 
(Beckmann et al., 1990). 
 
   2.1.3.2. IgH intronic enhancer (Eµ enhancer) 
 
 The intronic enhancer is located between the J regions and Cµ and 
spans approximately 220 bp sequence featuring octamer and C/EBP binding 
sites as well as a number of E box motifs (CANNTG), such as µE1, µE2, µE3, 
µE4, µE5, µA (Arulampalam et al., 1997; Engel and Murre, 2001; Ernst and 
Smale, 1995). The E box binding-proteins (E-proteins) like E2A belong to a 
subclass of basic helix-loop-helix (bHLH) factors that act as transcriptional 
activators and can homo- or heterodimerize on the E box motifs µE2, µE4 and 
µE5 (Hu et al., 1992; Murre et al., 1989). Additional motifs termed µA and µB 
were also implicated in the activation of IgH gene expression. These binding 
sites are recognized by the transcription factors of the Ets family, including 
Ets-1, Ets-2 and Elf-1, which can bind to the µA motif, and PU.1, which binds 
to the µB site (Nelsen et al., 1993; Rivera et al., 1993). The Ets transcription 
factors are characterized by a conserved DNA-binding domain (the ETS 
domain) that forms a HLH structure, which binds specific purine-rich DNA 
sequences with a GGA core (Crepieux et al., 1994; Sharrocks, 2001). They 
are generally weak activators of transcription by themselves and act mainly 




 Of great interest, the intronic enhancer is flanked by two MARs, 
consisting of A/T-rich sequences that associate with the nuclear matrix 
(Cockerill et al., 1987). They have been associated with the control of 
chromatin structure of entire gene loci and thus overlap functionally with locus 
control regions (LCRs). The MARs can contribute positively to Eµ function by 
enhancing transcription from a transgene promoter (Forrester et al., 1994; 
Jenuwein et al., 1997). In addition, MARs have been implicated in constituting 
physical boundaries between genes by forming chromosome loops (Cockerill 
and Garrard, 1986; Cockerill et al., 1987). 
 
   2.1.3.3. 3’ IgH enhancer 
 
 The 3’ IgH enhancer is located downstream of the IgH locus, 3’ of the 
Cα region. It spans over 30 kb and encompasses four DNase I hypersensitive 
(HS) sites with enhancer activity termed HS1 to HS4. The initially identified 
major enhancer region, whose activity is inducible in activated B cells and 
plasma cells contains HS1 and HS2 sites. It was discovered early that during 
B cell activation, an octamer site present in several of the 3’ enhancer 
elements is crucial (Yuan et al., 1995) as well as the interaction of Oct-2 and 
its coactivator OBF-1 with the 3’ IgH (Tang and Sharp, 1999). 
 It is generally believed that the 3’ IgH enhancer plays an important role 
in the high expression of switched Ig loci in plasma cells compared to 
unswitched loci, presumably because it is then brought into the vicinity of the 
VH promoter and interacts with it. 
 
   2.1.3.4. Igll1-VpreB gene control elements 
 
 The regulatory elements required for correct levels of expression and 
controlling time-specificity of Igll1 and VpreB are located within a 19 kb 
fragment containing both genes. This fragment was shown to contain a LCR 
that is able to promote efficient and stage-specific expression of both genes. 
This LCR, having strong enhancer activity, includes a cluster of five DNase I 
HS sites located 3’ of the Igll1 gene. There is also evidence that additional 
elements located elsewhere in the locus can contribute to the LCR effect : 
sequences that can enhance transcription in pre B cells have been identified 
in the Igll1 promoter, in two HS sites (HS7 and HS8) in the intergenic region 
and in the HS1 site. This is an interesting picture of regulatory elements 
distributed across the locus instead of being concentrated into a discrete unit 
of multiple HS site like it is the case for the β-globin LCR (Sabbattini and 
Dillon, 2005). 
 The observation that the promoters of Igll1 and VpreB genes contain 
multiple binding sites for EBF and E2A in addition to in vivo study 
(Sigvardsson et al., 1997) demonstrated the involvement of these two 
transcription factors in activating Igll1 and VpreB expression. Moreover, two 
adjacent binding sites for Ikaros are present in the Igll1 promoter and one of 
these sites overlaps with an EBF binding site. The fact that Ikaros binds DNA 
more efficiently as a dimer raised the possibility that co-operative binding of 
Ikaros to the two sites could repress Igll1 transcription by preventing binding 




specific silencing of the Igll1 gene in pre BI and mature B cells (Sabbattini et 
al., 2001; Thompson et al., 2007). 
 
  2.1.4. Transcription factors regulating Ig and surrogate 
light chain gene transcription 
 
   2.1.4.1. Oct factors and their coactivator OBF-1 
  
 The best studied transcription factors that interact specifically with the 
octamer motif in B cells are the POU homeodomain proteins Oct-1 and Oct-2. 
While Oct-1 is ubiquitous, Oct-2 is predominantly expressed in B cells, as well 
as in activated T cells and in the nervous system. Oct-1 and Oct-2 are 
members of the POU family of transcription factors (POU stands for Pit-1, 
Oct-1 and nematode Unc-86 ; for review see Herr and Cleary, Latchman and 
Philips and Luisi (Herr and Cleary, 1995; Latchman, 1999; Phillips and Luisi, 
2000)). The common characteristic of the POU family is the 150-160 amino-
acid bipartite DNA-binding domain (POU domain), consisting of two 
structurally independent subdomains : the homeodomain POUH (which is 
related to the DNA binding domain of homeobox proteins) and the specific 
domain POUS (which is unique to the POU factors). Oct-1 and Oct-2 show 
identical DNA-binding activities and share 90% sequence identity in their 
DNA-binding POU domain, but differ in other protein regions, mostly in the C-
terminal activation domain (Tanaka et al., 1992). The analysis of Oct-2 
deficient mice showed that this factor is required for B cell maturation and 
also, surprisingly, for postnatal survival (Corcoran and Karvelas, 1994; 
Corcoran et al., 1993). Oct-1 appears to rely on co-operative binding with 
other factors to achieve its full activation potential. Ternary complex formation 
with tissue-restricted coactivators, such as OBF-1 (Ford et al., 1998) can 
increase the specificity of the transcriptional activation mediated by Oct 
factors. While it was known early that Oct-1 and Oct-2 can bind to DNA 
elements as monomers (Staudt et al., 1986), it was discovered only recently 
that they can form homo- and heterodimers on specific octamer-related DNA 
motifs : the PORE (Palindromic Oct-factor Recognition Element : 
ATTTGAAATGCAAAT) and the MORE (More PORE : ATGCATATGCAT) 
(Remenyi et al., 2001; Tomilin et al., 2000). This can confer additional 
selectivity. 
 OBF-1 (OCA-B, Bob-1) is a proline-rich lymphoid-specific 
transcriptional coactivator protein that interacts with the POU domains of Oct-
1 or Oct-2 and with the conserved octamer element on the DNA (Gstaiger et 
al., 1996; Luo and Roeder, 1995; Strubin et al., 1995). OBF-1 strongly 
potentiates transcription from octamer-containing promoters such as Igκ light 
chain promoter in transcription assays and in vitro (Luo and Roeder, 1995; 
Schubart et al., 1996). OBF-1 seems to play a role for cell survival at early B 
cell stages, since a significant reduction of transitional (immature 493+) B cells 
in the spleen was observed by FACS analyses, indicating a malfunction in the 
B cell homing from bone marrow to the spleen in the absence of OBF-1 
(Schubart et al., 2000) or an impaired production of transitional B cells in the 
bone marrow of OBF-1 deficient mice (Hess et al., 2001). Importantly, 
histochemical studies have shown that OBF-1 function is crucial for the 




OBF-1 deficient mice. As a consequence, these mice have defects in the Ag-
dependent B cell development and show a strongly impaired immune 
response to T cell-dependent Ags (Kim et al., 1996; Schubart et al., 1996). 
Interestingly, structural and functional data have demonstrated that, at least 
on some of the Ig heavy chain promoters, Oct-1 binds to the octamer site in a 
dimeric conformation (MORE) that precludes recruitment of OBF-1 to the DNA 
(Tomilin et al., 2000). In B cells, the B29 and mb-1 promoters are directly 
targeted by OBF-1 (Malone and Wall, 2002). The severe reduction of the 
number of immature B cells observed in the spleen of OBF-1 deficient mice is 
even more dramatic in OBF-1/Oct-2 (Schubart et al., 2001) and OBF-1/btk 
(Bruton’s tyrosine kinase) compound mutant mice (Schubart et al., 2000). In 
line with this, mice lacking simultaneously OBF-1 and the chromatin regulator 
Aiolos show a severe developmental block in the bone marrow, at the 
transition between Pre B and immature B cells (Sugai et al., 2003; Sun et al., 
2003). This phenotype is all the more surprising given the fact that the 
individual knockouts of these two factors show defects only in late stages of B 
cell development. However, OBF-1 is critical for the activity of a subset of IgL 
promoters (Casellas et al., 2002). 
 Apart from OBF-1, investigation in mice revealed that Aiolos is a Ikaros 
family factor crucial for the function of mature B cells in the periphery. 
 
   2.1.4.2. Ikaros and Aiolos 
 
 Ikaros is the founding member of a growing family of krüppel-like zinc-
finger transcription factors. Gene targeting studies in mice have shown that 
inactivation of Ikaros family proteins leads to a complete absence of B, T, NKs 
and DCs, whereas a reduction of Ikaros activity induce hyperproliferation and 
lymphomas (Georgopoulos et al., 1997; Takanashi et al., 2002; Winandy et 
al., 1995). Like the Drosophila protein hunchback, Ikaros proteins are 
characterized by a highly conserved C2H2 zinc-finger DNA-binding domain 
near the N terminus and a C2H2 zinc-finger protein-protein interaction domain 
near the C terminus. The latter mediates the formation of homo- or 
heterodimers and multimers between Ikaros family members, which is 
essential for the regulation of their functions (Georgopoulos et al., 1992; 
Hahm et al., 1994). 
 Upon alternative splicing, several isoforms of Ikaros are expressed 
(Fig.14 (Rebollo and Schmitt, 2003)). Long isoforms (Ik1 to Ik3) with at least 
three zinc fingers can efficiently bind to DNA, while shorter versions (Ik4 to 
Ik8) with less than three zinc fingers behave, upon dimerization, as dominant 
negative isoforms. The role of Ikaros in lymphoid development has been 
studied following Ikaros gene inactivation in mice, by deletion of exons 3 to 5 
leading to overexpression of a dominant negative Ikaros protein (Ikaros DN-/-
) ; these mice exhibited a complete lack of lymphoid cells (B, T, NKs and DCs) 
(Georgopoulos et al., 1994). A less drastic phenotype is observed in Ikaros 
null mutant resulting from targeting of exon 7, required for stable protein 
expression. In these mice, T cells still appears few weeks after birth, 
suggesting some complementation by a related protein (Wang et al., 1996). 
 A protein related to Ikaros was identified by degenerate PCR with 
primers complementary to sequences encoding the carboxy-terminal zinc 




Ikaros isoform, with strong similarities in the DNA-binding, activation and 
dimerization domains. It interacts with Ikaros through its carboxy terminal 
fingers (Morgan et al., 1997). Aiolos is first detected at low levels in early B 
and T cell precursors and its levels increase as they progress to more 
definitive stages of differentiation (pre B cells and double positive T cells). 
Aiolos expression increases further in peripheral B cells and peaks in 
recirculating B cell populations. Disruption of Aiolos leads to phenotypes that 
are consistent with its pattern of expression : an increase in pre B and 
immature B cells and a severe reduction in recirculating B cells (Wang et al., 
1998). 
 The interplay between Ikaros and Aiolos in the regulation of gene 
expression is further complicated by additional Ikaros and Aiolos isoforms 
(Fig.14 (Rebollo and Schmitt, 2003)) or by other proteins that can sequester 
either member in transcriptionally inert complexes. Variations in the 
expression levels of these factors are important for cell progression through 
the lymphoid lineage. Normal progression through B and T lineages requires 
the sequential expression of Ikaros/Ikaros, Aiolos/Ikaros and Aiolos/Aiolos 
complexes (Morgan et al., 1997), suggesting that both members act in concert 
to regulate lymphoid differentiation and function. 
 Ikaros and Aiolos can activate transcription by binding to given 
promoters via their common consensus DNA-binding site (C/TGGGAA/T with 
GGGA described as the core motif) (Molnar and Georgopoulos, 1994; Sun et 
al., 1996). Although Ikaros and Aiolos share similarity in the activation 
domain, Aiolos is a stronger activator in mammalian cells. Moreover, a study 
revealed that Ikaros may not be a typical transcriptional activator since it was 
found to localize primarily to centromeric heterochromatin in B cells (Brown et 
al., 1997; Klug et al., 1998). Therefore, Ikaros may recruit genes that are 
destined for inactivation to centromeric foci. In the same line, the Ikaros-
Helios complexes localize to the centromeric region of T cell nuclei. However, 
only a fraction of Ikaros exhibited a centromeric localization, presumably the 
fraction associated to Helios, suggesting that Helios is a limiting regulatory 
subunit for Ikaros within T cell centromeric heterochromatin (Hahm et al., 
1998). Helios-Ikaros complexes might bind to DNA sequence elements within 
the promoters, enhancers, or silencers of genes that require repression ; 
especially, centromeric foci are characterized by γ-satellites (Hahm et al., 
1998). Of great interest, while Ikaros is expressed throughout the ontogeny of 
lymphoid cells, a diminution of its activity by means of overexpression of a 
dominant negative isoform in T lymphocytes leads to hyperproliferation, loss 
of heterozygosity and malignant T cell development (Wang et al., 1996). The 
restructuring of chromatin is obviously a key aspect of Ikaros function in 
lymphocyte development. Not only Ikaros proteins may be involved in gene 
silencing but, also and importantly, by colocalizing with DNA replication foci, 
they may control the stable propagation of genetic material (Avitahl et al., 
1999; Wang et al., 1998). 
Among key developmental genes for the B lineage, the Igll1 gene, 
which encodes the pre-BCR component λ5 is tightly regulated by Ikaros and 
Aiolos. In pre BI cells, Ikaros modulates λ5 expression in competition with the 
transcriptional activator EBF. At the transition from the pre BI to the pre BII 
stage, the expression of Aiolos is upregulated and required for the efficient 


























































Figure 14 : Ikaros and Aiolos isoforms. Schematic representation of the various isoforms described for Ikaros and 













accompanied by DNA (CpG) methylation, delayed replication in S phase 
(Azuara et al., 2003), or a drastic reduction in chromatin accessibility 
(Sabbattini et al., 2001) but with repositioning to the vicinity of pericentromeric 
heterochromatin (Brown et al., 1997). Ikaros proteins may drive this by 
binding to high-affinity sites in pericentromeric γ-satellite repeats (Cobb et al., 
2000); also, silencing involves increased Aiolos occupancy of the Igll1 
promoter. 
 In erythroid cells, Ikaros is not detectable as free protein but only found 
associated to chromatin-remodeling complexes. Alternatively, Ikaros may also 
be in complex with a similar Ikaros-like protein and/or perhaps with erythroid-
specific factors such as GATA-1 (O'Neill et al., 2000). An Ikaros-GATA-1 
interaction has been hypothesized but never identified. Most likely because 
biochemical purification of Ikaros-associated complexes has been generally 
carried out in lymphoid cells and most importantly, because beside Ikaros 
interaction with other Ikaros family proteins, it is known that Ikaros forms low 
stability complexes with other proteins in vivo, which might not resist high 
stringency washes (Bottardi et al., 2009). 
 
   2.1.4.3. Other key transcription factors in B cell 
development 
 
 Other Ikaros family members such as Helios, Eos and Pegasus are 
also expressed in B cells (Perdomo et al., 2000). Their function in this lineage 
remains poorly reported if at all. Ets factors, such as PU.1 and Spi-B, E2A, 
EBF, PAX-5, SOX4 (sex-determining region Y box 4), Lef-1 (lymphoid 
enhancer binding factor 1), IRFs (interferon-regulatory factor), the NF-κB 
family, BCL-6 (B cell lymphoma 6), XBP-1 (X-box-binding protein 1) and 
Blimp-1 (B lymphocyte induced maturation protein 1) are further discussed. 
 PU.1 – a transcription factor of the ETS family – is a protein crucial in 
the early stages of haematopoietic-cell lineage specification. Pu.1-/- mice die 
during embryonic development at day 18.5 (E18.5) ; they lack B and T cells, 
monocytes, and granulocytes (McKercher et al., 1996; Scott et al., 1994). 
The highly related ETS protein SPI-B, expressed at all stages of B cell 
development (similarly to PU.1) cannot compensate for the absence of PU.1. 
Indeed, expression of SPI-B from the Pu.1 locus in mice was found to rescue 
myeloid differentiation but not defect in lymphopoiesis, arguing for specific 
roles of these two proteins in haematopoietic-cell development (Dahl et al., 
2002). 
The gene that encodes E2A is a founding member of the bHLH gene 
family ; it encodes the broadly expressed E12 and E47 proteins (collectively 
known as E2A), generated by alternative splicing. Because these proteins 
bind the E box – CANNTG (where N denotes any nucleotide), a motif initially 
identified in the mouse IgH enhancer-, they are known as E-box factors or E 
proteins. Although the E2a gene is widely expressed, its mutation in mice 
leads to defects that are most marked in the B cell lineage (Bain et al., 1994; 
Kee et al., 2000), but other cell lineages (such as T cells) are also affected 
(Bain et al., 1997). 
EBF is a transcription factor expressed specifically by pro B, pre B and 
mature B cells ; it has been implicated in the regulation of the B cell specific 




leads to a very early block in B cell differentiation, similar to the block 
observed in the absence of E2A (Lin and Grosschedl, 1995). 
PAX-5 is a paired homeodomain protein expressed by B cells and in 
the nervous system at the midbrain-hindbrain boundary. Mutation of the Pax5 
gene leads to a complete block in B cell differentiation downstream of the 
block seen in the absence of E2A or EBF (Urbanek et al., 1994). 
The transcription factors SOX4 and Lef-1 are members of the high 
mobility group (HMG)-box family and have a crucial role at an early stage of B 
cell development. Mice lacking SOX4 die at E14 due to a defect in cardiac 
formation. However, when Sox4-/- fetal liver cells were used to reconstitute the 
haematopoietic system of lethally irradiated mice, a very strong block was 
observed at the pro B to pre B cell transition (Schilham et al., 1996). In Lef-1-/- 
mice, the size of the B cell compartment is reduced (Reya et al., 2000). 
IRF4 and IRF8 are highly related factors that are expressed in both 
lymphoid- and myeloid-lineages. Mice lacking IRF4 have normal B cell 
development but greatly impaired B and T cell activation, resulting in a 
strongly impaired immune response (Rettig et al., 1997). By contrast, mice 
lacking IRF8 show defects in macrophage development and have a chronic-
myeloid-leukaemia-like phenotype (Holtschke et al., 1996). 
NF-κB is an inducible transcription factor comprising related proteins 
(Ghosh et al., 1998). Ablation of various NF-κB subunits in mice revealed that 
early B cell development and immunoglobulin-gene transcription do not 
require this factor. Instead, several aspects of late B cell differentiation and/or 
maturation are affected by the absence of NF-κB (Sha et al., 1995). 
 IRF4, BCL-6 and XBP-1 are involved in the terminal differentiation of B 
cells into plasma cells. In B cells deficient in Blimp-1, plasma cell 




 2.2.1. Definitions 
 
 When Conrad Waddington coined the word ‘epigenetics’ (literally ‘over’ 
or ‘upon’ genetics) in the early 1940s, the term was used to explain why 
genetic variations sometimes did not lead to phenotypic variations and how 
genes might interact with their environment to yield a phenotype. However, 
the word currently refers specifically to the study of heritable changes in gene 
expression that occur during mitosis or meiosis without changes in the DNA 
sequence (Berger et al., 2009). The disruption of such changes underlies a 
wide variety of pathologies, including cancers (Esteller, 2008). Epigenetic 
regulation includes heritable modifications of the DNA –such as cytosine 
methylation- and aspects of chromatin structure –including histone 
modifications-. 
 
  2.2.2. The CtBP complex 
 
 The vertebrates have two CtBP genes. Genetic studies indicate that 
the CtBP genes play pivotal roles in animal development. The vertebrate C-




functionally redundant for certain developmental processes and non 
redundant for others. CtBP proteins are evolutionarily-conserved, non DNA-
binding co-regulator phosphoproteins, interacting with sequence-specific DNA 
binding transcriptional regulators. The corepressor complex of CtBP1 contains 
enzymatic constituents that mediate coordinated histone modification by 
deacetylation (histone deacetylases, HDACs) and methylation and 
demethylation (CoREST and LSD1) (Chinnadurai, 2007). Notably, CtBP is a 
BCL-6 corepressor ; during the GC stage of B cell development, CtBP is 
required for BCL-6 autoregulation and subsequently for the control of the 
expression of other BCL-6 target genes (Mendez et al., 2008). Well-known as 
a repressor complex, the CtBP complex can nevertheless mediate activation 
of some targets (Fang et al., 2006). 
 
  2.2.3. The NuRD complex 
 
 The NuRD complex was first purified about a decade ago in cells from 
different species, and it contains six core subunits. In mammals, the subfamily 
II members CHD3 and CHD4 are subunits of NuRD complexes. The latter 
also contain HDACs and function generally as transcriptional repressors. 
Mammalian NuRD complexes achieve diversity in regulatory function through 
combinatorial assembly. The core ATPase is CHD3 or CHD4. HDAC1 and 
HDAC2 catalyse protein deacetylation. There are three main accessory 
subunits, which are encoded by gene families : MTA (metastasis-associated), 
MBD (Methyl-CpG-binding domain) and RbBP (retinoblastoma-associated-
binding protein). Each complex contains one MTA protein : MTA1, MTA2 or 
MTA3. These are mutually exclusive and nucleate complexes with markedly 
different, and sometimes opposite, functions. Each complex also contains 
MBD2 or MBD3, which are functionally distinct and contribute to different 
forms of the complex, and RbBP4 and/or RbBP7. The RbBP4 and RbBP7 
subunits are thought to be structural components of the NuRD complex and 
have been shown to directly associate with histone tails. The composition of 
the NuRD complexes varies with cell type and in response to signals within a 
tissue, giving rise to a diversity of complexes with distinct functions (Ho and 
Crabtree). For instance, the transcriptional repressor BCL-6 regulates B 
lymphocyte cell fate during the GC reaction by preventing terminal 
differentiation of B lymphocytes into plasma cells until appropriate signals are 
received. The cofactor MTA3, a cell type-specific subunit of the corepressor 
complex NuRD is required for BCL-6-dependent cell fate determination (Fujita 
et al., 2004). The NuRD complex is involved in the transcriptional regulation of 
key genes that promote the progression of T and B lymphocyte development. 
Transcriptional repression of multiple lineage-specific genes by the NuRD 
complex during haematopoiesis is mediated through Friend Of GATA-1 (FOG-
1), which binds MTA family proteins and recruit NuRD to GATA family 
transcription factors. Other haematopoietic lineage-specific transcription 









2.2.4. Other key epigenetic regulator complexes 
 
 Sin3 and PRC2 (Polycomb Repressive Complex 2) complexes are two 
other epigenetic complexes containing RbBP4 and RbBP7. 
 Besides, SWI/SNF complexes are crucial for the proper development 
of all organisms. The second family of SWI-like ATP-dependent chromatin-
remodeling complexes is the ISWI family. The ISWI ATPase is the core 
component of three types of ISWI complex : NuRF (nucleosome remodeling 
factor), ACF (chromatin-assembly factor) and CHRAC (chromatin accessibility 
complex) complexes. The third family of SWI-like ATP-dependent chromatin-
remodeling complexes is the CHD family. Theses complexes contain 
members of the CHD family of ATPases, which comprises nine 
chromodomain-containing members. CHD proteins are broadly classified into 
three subfamilies based on their constituent domains : subfamily I (CHD1 and 
CHD2), subfamily II (CHD3 and CHD4) and subfamily III (CHD5, CHD6, 
CHD7, CHD8 and CHD9). The last family of SWI-like ATP-dependent 
chromatin-remodeling complexes is the INO80. These complexes contain 
INO80 ATPases, which in mammals include INO80 and SWR1 and are 
characterized by the presence of a conserved split ATPase domain. The 
INO80 and SWR1 complexes are large multisubunit machines with in vitro 
nucleosome-remodeling activity, which might contribute to their in vivo roles in 
transcriptional regulation (Ho and Crabtree). 
 
3. FOG-1, a master developmental cofactor within the 
haematopoietic system 
 
Haematopoiesis is a highly regulated multi-step process controlled by 
transcription factors and epigenetic modifiers. From a very small population of 
self-renewing, pluripotent HSCs, all specialized and distinct blood cell types 
arise. During the proliferation, differentiation and maturation of pluripotent 
HSCs, cellular specification and commitment are initiated by primary lineage 
determinants, such as the cofactor FOG-1. 
Within the haematopoietic cells, FOG-1 expression is restricted : it is 
detected at high level in early multipotent progenitors, erythroid and 
megakaryocytic cells, low level in HSCs and lymphoid cells, and it is absent 
from myeloid lineages (Cantor and Orkin, 2005). 
Zfpm1 encodes the developmental regulator FOG-1. It is a multitype 
zinc finger protein of 995 and 1006 amino acids in the mouse and human, 
respectively. FOG-1 interacts with the DNA-binding transcription factor GATA-
1 (Tsang et al., 1997). Aside from GATA-1, three main interacting partners of 
FOG-1 have been defined : CtBP and the NuRD complex, which both link 
FOG-1 to chromatin regulation, and transforming acidic coiled-coil 3 (TACC3), 
which sequesters FOG-1 in the cytosol (Fox et al., 1999; Garriga-Canut and 
Orkin, 2004; Hong et al., 2005). 
This review summarizes genetic and biochemical evidence underlying 
the key role of FOG-1 as a primary determinant of haematopoietic cell fate. 
Current facts showed its substantial role in the cell fate control of HSC and 
progenitor populations rather than in the maturation of terminally differentiated 
cells. FOG-1 functions are intrinsically linked to its nuclear interactors, which 




3.1. FOG-1 functions in embryonic stem cells 
 
The transcriptional cofactor FOG-1, like the transcription factors GATA-
1, GATA-2 and Ikaros, is stably expressed in Lin-Sca+ HSC over a limited 
number of time points of culture in IL-3, IL-6, IL-11, and steel factor (Dooner et 
al., 2008). 
The analysis of the functions of FOG-1 in mouse embryonic stem (ES) 
cells was mainly performed by Tanaka et al. (Tanaka et al., 2004). Using a 
TET-Off conditional gene expression system, they overexpressed FOG-1 in 
ES cell line in the presence of tetracycline and could show that FOG-1 
misexpression in ES cells induced cell cycle arrest at the G0/G1 phase. 
Similar enforced expression of FOG-1 in GATA-1 null ES cells lead to an 
inhibitory proliferation effect of FOG-1, suggesting a GATA-1 independent role 
of FOG-1 in this cellular setting. On the contrary and interestingly, the 
overexpression of FOG-1 mutant unable to bind CtBP did not affect ES cell 
proliferation and morphology. As a result, FOG-1/CtBP interaction may well 
be crucial for regulating the proliferation of ES cells (Fig. 15 (Tanaka et al., 
2004)). 
 
3.2. FOG-1 functions in the myeloid compartment 
 
 3.2.1. FOG-1, a master regulator of erythroid and 
megakaryocytic differentiation 
 
Zfpm1-/- mice die between E10.5 and E12.5 of gestation from severe 
anaemia with a developmental block during erythropoiesis and a failure of 
megakaryopoiesis (Tsang et al., 1998). In both Zfpm1-/- and GATA-1- mice, 
the block in erythroid maturation was observed at the proerythroblast stage 
(Fujiwara et al., 1996). This was providing genetic evidence that FOG-1 and 
GATA-1 functions were coordinately linked in erythroid development ; which 
was expected according to biochemical data demonstrating that FOG-1 acts 
as a cofactor for GATA-1 at least in erythroid differentiation (Tsang et al., 
1997). Nevertheless, contrary to GATA-1- mice, Zfpm1-/- mice exhibited a 
complete failure of megakaryopoiesis. FOG-1 might therefore directs 
megakaryocyte development independently of GATA-1. 
So far, in the erythroid lineage, FOG-1 molecular mechanism of action 
was mainly associated to GATA-1 ; especially in the chromatin context, FOG-
1/GATA-1 interaction was well-described to trigger RBC differentiation by 
tighly orchestrating gene regulation. For instance, Ikaros in complex with 
GATA-1, FOG-1 and NuRD complex components is responsible for human β-
globin gene regulation in mouse transgenic erythroid cells (Bottardi et al., 
2009). Moreover, in the nucleus of GATA-1 erythroid committed cell line G1E, 
FOG-1 mediates activation or silencing of genes by facilitating chromatin 
occupancy by GATA-1 at sites bound by GATA-2 (Fig. 16 (Pal et al., 2004)), 
by recruiting epigenetic modifiers or by stabilizing tissue-specific chromatin 
loops (Vakoc et al., 2005). FOG-1 has also been shown to be required for 
reconfiguring higher order chromatin organization via GATA factor exchange 

























Figure 15 : Schematic diagram of the effects of overexpressing FOG-1 and FOG-1ΔCtBP in the wild-type and GATA-





















In addition, recent genetic studies showed that FOG-1 mediated 
recruitment of NuRD was required for re-enforcing the engagement towards 
erythrocyte and megakaryocyte differentiation during haematopoiesis (Gao et 
al.). This was confirming in vitro findings from Hong et al. : they isolated the 
NuRD repressor complex in a GST pull-down assay using the N-terminal 
domain of FOG-1 as prey in MEL cell ; they additionally demonstrated that in 
G1E cells, the ability of GATA-1 to repress transcription was impaired while 
overexpressing a FOG-1 disrupted in the NuRD-binding site (Hong et al., 
2005). According to Rodriguez et al. work, overlapping functions of FOG-1 
and GATA-1 in erythropoiesis occur in the context not only of the GATA-
1/FOG-1 complex but also of the GATA-1/FOG-1/MeCP1 (Rodriguez et al., 
2005). The association with MeCP1 provided an additional molecular basis for 
the well-documented repressive properties of FOG-1 and GATA-1 interactions 
(Crispino et al., 1999; Fox et al., 1999; Letting et al., 2004; Pal et al., 2004). 
In megakaryocytes, FOG-1 molecular mechanism of action is less well-
known. However, mice in which FOG-1/NuRD interaction is disrupted display 
defects similar to germline mutations in the Zfpm1 and Gata1 genes, including 
anaemia and macrothrombocytopenia. Miccio et al. provided clear evidence 
that NuRD is involved in several key functions of FOG-1 in the erythroid and 
megakaryocyte lineages (Gregory et al.; Miccio et al.). 
 
 3.2.2. FOG-1, a cofactor balancing differentiation in the 
granulocyte/monocyte progenitor derived cells 
 
FOG-1 expression in myeloid (neutrophil, granulocyte and 
macrophage) progenitors inhibits mast cell differentiation and enhances 
development of neutrophils. Especially, cells with overexpression of FOG-1 
expressed Gr-1 and Mac-1 genes and displayed phagocytic activity 
(neutrophilic characteristics). Otherwise, in mature mast cells, FOG-1 
reprogrammed the fate of differentiated cells into multipotent progenitors. 
From forced expression studies in both cell lines and primary cells, it is 
evident that GATA-1 and PU.1, two FOG-1 interactors are able to specify 
erythroid and myeloid cell fates (Heyworth et al., 2002). FOG-1 is not 
expressed in mast cells. Nevertheless, mast cell differentiation was clearly 
driven by the molecular and functional interactions between GATA-1, PU.1 
and FOG-1. On the contrary, the loss of the mast cell phenotype was not 
arising from disruption of the complex between the GATA factors and PU.1 
but would rather be caused by the down-regulation of MITF, a gene encoding 
an essential mast cell regulator (Sugiyama et al., 2008). In addition, FOG-1 
reduced the mRNA of transcription factors and mast cell-specific genes such 
as PU.1, c-Kit, mast cell protease 4 (p4), mast cell protease 5 (p5), mast cell 
protease 6 (p6), granzyme B (granB) and tryptophan hydroxylase (tph). 
Confirming FOG-1 involvement in the correct establishment of mast cell 
lineage specific gene expression, Maeda et al. demonstrated that FOG-1 
expression level regulated the GATA-1 dependent FcepsilonRI beta-chain 
promoter (Maeda et al., 2006). Notably, FcεRIβ-chain or mouse high-affinity 
IgE receptor is involved in IgE-dependent allergic reaction, and, therefore 
linked to IgE-dependent allergic disease. Moreover, results occuring from 
cells cultured from male GATA-1- or GATA-1V205G (non-FOG-1-binding GATA-





































Figure 16 : Left panel. Structure of the GATA/FOG complex. Ribbon diagram of the lowest energy structure of the 
complex. Zinc ion are shown in gray and zinc-ligating side chains are shown in gold and blue. Right panel. Model of 
chromatin occupancy of GATA factors and FOG-1. GATA-1-FOG-1 and GATA-2-FOG-1 complexes switch at the 




















proteins in terminal mast cell development (Cantor et al., 2008). 
Also, the finding that FOG-1 was rather required for the development of 
the thrombocytic lineage at a very early stage (Tsang et al., 1998) led to 
examine the role of FOG-1 in the generation of MEPs and their differentiation. 
MEPs, but not eosinophils or myeloid cells express high levels of FOG-1. This 
could partially explain the role for FOG-1 in the GATA-1 mediated conversion 
of myeloid cells to a multipotent phenotype ; GATA-1 was indeed able to 
reprogram HD50M avian myelomonocytic cell line into MEPs and eosinophils 
(Kulessa et al., 1995). Moreover, expression of FOG-1 in avian eosinophils 
leads to the acquisition of a multipotent phenotype (Querfurth et al., 2000). 
Remarkably, myeloid cell types are characterized by the expression of PU.1 
and C/EBP transcription factors, which regulate most myeloid-specific 
promoters (Tenen et al., 1997). Down-regulation of FOG-1 notably coincides 
with and is a prerequesite for the C/EBPβ-mediated up-regulation of 
eosinophils specific gene expression in MEPs. Concomitant with FOG-1 
down-regulation, up-regulation of mim-1 expression, which is an 
eosinophil/myeloid-specific marker was observed. Besides, some of the 
processes that are negatively affected by loss or misexpression of FOG-1 in 
the myeloid compartment are reminiscent of the B cell reprogramming into 
macrophages following ectopic expression of C/EBPα and C/EBPβ (Xie et al., 
2004). 
 
3.3. FOG-1 functions in the lymphoid compartment 
 
FOG-1 plays a role in the T lineage by repressing GATA-3-dependent 
induction of Th2 development. Indeed, in reporter assays, FOG-1 can repress 
GATA-3-dependent activation of several cytokine promoters in T cells and 
notably the IL-5 promoter. Also, FOG-1 overexpression during primary 
activation of naive T cells, which express significant levels of FOG-1 mRNA 
inhibited Th2 development in CD4+ T cells. In fact, FOG-1 mRNA is rapidly 
down-regulated upon commitment to both Th1 and Th2 lineages. Moreover, 
retroviral expression of FOG-1 in developing Th2 cells suppressed both IL-4 
and IL-5 and allowed for IFN-γ production, which was accompanied by a 
significant level of T-bet mRNA expression. FOG-1 fully repressed GATA-3-
dependent Th2 development and GATA-3 autoactivation, but not Stat6-
dependent induction of GATA-3. Although FOG-1 overexpression repressed 
development of Th2 cells from naive T cells, it did not reverse the phenotype 
of fully committed Th2 cells (Zhou et al., 2001). Using the GATA-3 Nf as a bait 
in a yeast two-hybrid screening, Kurata et al. identified FOG-1 in the Th2 cell-
specific library. Serial deletion mutation analysis indicated that the N-terminal 
region, but not the consensus CtBP-binding motif of FOG-1 is critical for the 
effects. The results clearly indicate that first of all FOG-1 is a repressor of 
GATA-3 in naive T cells and second the down-regulation of FOG-1 induces 
Th2 differentiation by releasing GATA-3 from its repression (Kurata et al., 
2002). 
To conclude, appropriate expression of FOG-1 within the 
«haematopoietic tree» is crucial for normal cell commitment (Fig. 17). 
The role of FOG-1 in the B lineage is presented in the article entitled 





















Figure 17 : FOG-1 requirement and impact during haematopoietic development. Processes that are negatively 
affected by loss or misexpression of FOG-1 are indicated by red and green crosses, while those that are enhanced 

















Chapter 2 : Research publications 
 
1. Inappropriate hematopoietic expression of FOG-1 
does not affect B cells but reduces the number of 
circulating eosinophils 
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 Control  R26FOG-1:Vav-iCre  
 Males Females Mean Males Females Mean 
RBC 
(10^4/uL) 
1054 1032 979 1132 1049  1063 1136 1100 1067 1091  
HGB (g/L) 177 166 169 172 171  160 172 183 166 170  
HCT  
(10^(-1)%) 
534 505 508 516 515  492 525 532 507 514  
PLT 
(10^3/uL) 
1124 1352 914 1399 1197  1292 1241 1172 831 1134  
WBC 
(10/uL) 
855 901 1595 1305 1164  653 573 1434 1314 993  
LYMPH 
(10/uL) 
602 657 1205 970 858  485 412 1081 978 739  
MONO 
(10/uL) 
150 130 255 207 185  75 106 230 226 159  
NEUT 
(10/uL) 
79 83 87 92 85  82 49 107 103 85  
BASO 
(10/uL) 
0 0 1 0 0  0 0 0 2 0.5  
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Supporting Figure 2 Du Roure et al.  
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sample / control Standard error
CtBP1 O88712 48 kDa 3448 716
FOG-1 O35615 106 kDa 2348 191
Chd4 Q6PDQ2 218 kDa 3.4 0.1
HDAC2 P70288 55 kDa 3.2 0.5
HDAC1 O09106 55 kDa 3.1 0.3
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Supplementary Figure 8 
Versavel et al.
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Tryptic peptides in the sequence of full-length FOG-1 Positions of the phosphoacceptor sites (pS) in full-length FOG-1
284-AGS*PVSATEEKPK-296 pS286
393-GEIYS*PGAGHPAAK-406 pS397
495-TPS*PHS*PNPVR-505 pS497 or pS500
637-APAGAAAEPDPSRS*S*PGPGPR-657 pS650 or pS651
675-GS*EGS*QS*PGS*S*VDDAEDDPSR-695 pS676 or pS679 or pS681 or pS684 or pS685
925-S*PSPAPENTPSDPADQGAR-943 pS925
The numbers preceding and following each peptide denote the position of the first and last amino acids of the tryptic peptides.
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FOG-1 O35615 106 kDa 31 13,0% 78 30,0% 131 39,0% 130 35,0% 220 40,0%
CtBP1 O88712 48 kDa 3 9,3% 8 10,0% 17 27,0% 25 13,0% 76 20,0%
HDAC1 O09106 55 kDa 4 10,0% 1 1,9%
HDAC2 P70288 55 kDa 1 6,1% 1 3,7%
RCOR1 Q8CFE3 52 kDa 1 2,5%
ZEB2 Q9R0G7 136 kDa 1 0,7% 5 2,7%
Chd4 Q6PDQ2 218 kDa 2 0,9% 3 1,1% 5 3,4%
HDAC1 O09106 55 kDa 4 10,0% 1 1,9%
HDAC2 P70288 55 kDa 1 6,1% 1 3,7%
MBD3 Q9Z2D8 32 kDa 1 5,6% 3 5,3%
MTA1 Q8K4B0 81 kDa 3 4,9% 1 1,4%
MTA2 Q9R190 75 kDa 2 4,2%
RbAp48 (RBBP4) Q60972 48 kDa 1 2,8% 2 3,5% 2 8,5%
RbAp46 (RBBP7) Q60973 48 kDa 2 3,8%
Transcription machinery
Aiolos B1AQE6 58 kDa 1 2,2%
Ikaros1 Q03267 57 kDa 1 3,3% 1 3,3% 1 3,3% 2 3,3%
RUNX1 Q03347 49 kDa 1 3,3% 2 3,3% 5 12,0%
GZP1 Q3U063 97 kDa 1 1,8%
TIF1B Q62318 89 kDa 1 1,9% 2 6,5% 4 9,1%























Ikaros1 Q03267 57 kDa 136 26,0% 72 24,0%
CtBP complex
CtBP1 O88712 48 kDa 18 21,0% 4 8,4%
HDAC1 O09106 55 kDa 5 6,4% 3 5,0%
HDAC2 P70288 55 kDa 1 4,3% 1 5,0%
KDM1 (LSD1) Q6ZQ88 93 kDa 1 1,8%
NuRD complex
Chd4 Q6PDQ2 218 kDa 7 4,8% 2 1,9%
HDAC1 O09106 55 kDa 5 6,4% 3 5,0%
HDAC2 P70288 55 kDa 1 4,3% 1 5,0%
MTA2 Q9R190 75 kDa 5 9,7% 4 4,2%
RBBP4 Q60972 48 kDa 7 11,0% 5 6,4%
RBBP7 Q60973 48 kDa 6 8,9% 4 4,9%
Transcription machinery
Aiolos B1AQE6 58 kDa 66 42,0% 22 19,0%
FOG-1 O35615 106 kDa 3 1,7%






Aiolos 5'-ACA GCA GAC CAA CCG GTG GGA A-3' 5'-ACT GGA ACG GGC GTT CGC-3'
epcam 5'-CAC AGA ATA CTG TCA TTT GC-3' 5'-AGC ACG TGG CGG TGC CGT TG-3'
FOG-1 5'-CCA ACT GTG AAC GCC ATC TC-3' 5'-GAT CTC ACC CTT GGA GCC TG-3'
GAPDH 5'-GCC TCG TCC CGT AGA CAA AAT-3' 5'-TTC CCA TTC TCG GCC TTG A-3'





Chapter 3 : Discussion 
 
 The two papers previously presented already discuss the function of 
FOG-1 : in the haematopoietic system as far as the first article is concerned ; 
with in vitro work in the B cell lineage for the second one. Nevertheless, some 
points and additional experiments remain to be described and explained. First 
of all, a summary of the findings already available on the epcam gene, the 
gene found as a target of FOG-1 in B cell lines is discussed. Second, general 
data arising from the experiments done in mice overexpressing FOG-1 in the 
entire haematopoietic tree and from the proteomics performed in B cell lines 
give rise to further investigations. 
  
1. epcam ,  a gene involved in cancer 
 
A recent meeting report (Baeuerle and Gires, 2007) pointed out the 
importance of understanding the regulation of epcam at the transcriptional 
level. Key progress on epcam biological significance are recapitulated below. 
EpCAM (CD326; Gires, Atlas Genet Cytogenet Oncol Haematol, 2008) is a 
transmembrane glycoprotein showing frequent and high-level expression in 
numerous human malignancies including colon and breast cancers (Spizzo et 
al., 2004; Went et al., 2006). It is indeed known to induce cell proliferation via 
the induction of the proto-oncogene c-myc and the cyclin A and E genes 
(Munz et al., 2004). Moreover, it has been previously shown to be expressed 
at low level in a fraction of murine B and pre B lymphomas (Bergsagel et al., 
1992) and frequently as well as widely expressed on Cancer Stem Cells 
(Gires et al., 2009). Recently, tumour-associated antigen EpCAM was shown 
to mediate nuclear signaling explaining how this protein could function in cell 
proliferation (Maetzel et al., 2009). 
 
2. Investigation of FOG-1 function in the 
haematopoietic system 
 
2.1. In vivo 
 
To investigate FOG-1 function in vivo, we used R26FOG-1:VaviCre mice. 
Western blot analysis were performed to estimate the level of FOG-1 
overexpression in splenocytes and thymocytes derived from R26FOG-1:VaviCre 
animals. As shown in figure 18, an up-regulation in the overexpressing cells 
as compared to control cells was observed. We tried this assay on bone 
marrow cells but we unfortunately never could get proper results. 
Investigations in more detail of R26FOG-1:VaviCre mice would be 
required. Nevertheless, some preliminary results of blood analysis were quite 
promising. This was performed on 4 males (2 control and 2 R26FOG-1:VaviCre 
mice) and revealed a decrease of one third of the white blood cells, one third 
of the lymphocytes and one third of the monocytes in R26FOG-1:VaviCre mice 
(Fig. 19). Females were not analyzed yet. A preliminary explanation could be 
reminiscent of the phenotype observed in GATA-1.05/X mice. Indeed, these 
latter contain two types of haematopoietic cells, owing to the fact that GATA-1 







































Figure 18 : Up-regulation of FOG-1 protein in splenocytes and thymocytes derived from R26FOG-1:VaviCre mice. 
FOG-1, α-Tubulin and Actin were detected by western blotting in splenocytes derived from 7 control and 7 R26FOG-






one cell type, the X chromosome bearing the GATA-1.05 allele is inactivated, 
but the one bearing the wild-type GATA-1 allele is active. These 
haematopoietic progenitors express normal amounts of GATA-1 and are able 
to differentiate into their appropriate cell types, including enucleated 
erythrocytes and platelets. In the other cell type, the X chromosome bearing 
the GATA-1.05 allele is active, but the one bearing the wild-type GATA-1 
allele is inactive. In the latter case, the expression level of GATA-1 in erythroid 
and megakaryocytic progenitors is very low. This reduction appears to cause 
both arrest of differentiation and stimulation of proliferation (Shimizu et al., 
2004). Following X-inactivation in female R26FOG-1:VaviCre mice, GATA-1 is 
expressed randomly from the maternal X chromosome or from the paternal 
one ; which might lead to cells expressing GATA-1 at slightly different levels. 
On the contrary, in male R26FOG-1:VaviCre mice, GATA-1 is always expressed 
from the maternal X chromosome. Therefore, in all cells when FOG-1 is 
overexpressed, the pool of GATA-1 protein available is exactly the same 
leading to reproducible not attenuated effects arising from changes in the 
balance of FOG-1 partners available. 
Not surprisingly since FOG-1 is required for the differentiation of 
erythrocytes (Tsang et al., 1998; Tsang et al., 1997), we observed a 
moderately altered erythropoiesis in the spleen of some R26FOG-1:VaviCre 
animals. 
As discussed in the article “Inappropriate expression of FOG-1 does 
not affect B-cells but reduces the number of circulating eosinophils”, the highly 
significant diminution of the total number of circulating eosinophils should be 
investigated further. Experiments similar to those described in Mori et al.’s 
work (Mori et al., 2009) could be performed, especially colony forming assays.	
  
 
2.2. In vitro 
 
Biochemical experiments on FOG-1 in B cells revealed a number of 
interesting interactors that could actually further explain FOG-1 mechanism of 
action in red blood cells, where it is essential for differentiation as well as in 
other cellular settings. Among these factors, Aiolos, GZP1, Ikaros and TIF1B 
are of particular interest because their role in association to FOG-1 have 
never been addressed. In B lymphocytes, we showed that FOG-1 acts in a 
GATA-1 independent manner and more importantly in an Ikaros dependent 
manner at the transcriptional level. This is of great interest since so far in red 
blood cells, FOG-1 association with Ikaros has been suggested but always in 
conjunction with GATA-1 (Bottardi et al., 2009; Ross et al.). In addition, the 
proteomic analysis performed on the interaction of FOG-1 and Ikaros revealed 
that in all the pull-down experiments, the same peptide 
(257SNHSAQDAVDNLLLLSK273) inside Ikaros sequence was always 
recovered. It maps between Ikaros zinc finger 4 and 5 within the 
transactivation domain of the protein. It is also noteworthy that this peptide 
contains a compositional bias from position 268 till position 271 with 4 poly-
leucine, which might be involved in a hydrophobic pocket. To strengthen 
these results, in silico search with Pymol to see whether this peptide might be 
necessary and sufficient to interact with FOG-1 would be interesting. 
Depending on the results, crystalization assays with Ikaros peptide in complex 










Figure 19 : Reduction of circulating white blood cells, lymphocytes and monocytes. The numbers of white blood cells, 
lymphocytes and monocytes obtained in full blood count analysis of 2 control and 2 R26FOG-1:VaviCre mice were 







































are two zinc finger motifs with an unusual structure that is most similar to 
those encoded by the hunchbach gene in Drosophila. This domain mediates 
the formation of homo- or heterodimers and multimers between Ikaros family 
members, an essential feature for the regulation of their functions. Therefore, 
to further investigate the interaction between FOG-1 and Ikaros, generating a 
FOG-1 mutant in this dimerization zinc finger domain (zinc fingers 2 and 3) 
would be engaging. In parallel to FOG-1 partner search, a phosphorylation 
site analysis within FOG-1 protein was done by proteomics. Studies in the B 
cells showed that the FOG-1 serine 286 might be important for its function 
together with Ikaros. The pS286A FOG-1 mutant and the phosphomimetic 
pS286E FOG-1 mutant could be used to adress this question in other cellular 
settings where FOG-1 is known to be a critical factor. Considering the high 
number of phosphorylation sites identified by MS, the generation of different 
FOG-1 mutants for phosphoacceptor sites would be interesting. Notably, 3 of 
them (S397, S497 and S500) were found within the region between zinc 
fingers 4 and 5, whose function has not yet been assigned despite a high 
conservation between mouse and human. In addition, Snow et al. identified 
three phosphorylation sites near the canonical CtBP binding site (residues 
811-815) located at S803, S805 and S822 (Snow et al.). Given FOG-1/CtBP1 
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Chapter 5 : Appendix 
 
1. Impairment of B cell development in mice knock-
out for FOG-1 or overexpressing FOG-1 in the B cell 
compartment 
 
To investigate FOG-1 function in vivo, we used cFOG-1KO:mb-1Cre 
and R26FOG-1:mb-1Cre mice. Mice homozygous for FOG-1 conditional 
deletion were born with the expected Mendelian frequency. The same 
observation was done with mice overexpressing FOG-1 from the Pro B cell 
stage, indicating respectively that FOG-1 expression or reduced level of 
expression in B cells is not essential for survival in utero. cFOG-1KO:mb-1Cre 
animals and wild-type littermates were indistinguishable. Similarly, R26FOG-
1:mb-1Cre mice showed no apparent differences with their wild-type 
littermates. However, after whole bone marrow cell population extraction, 
analysis of the expression of B220, a B cell specific surface marker revealed 
some differences between cFOG-1KO:mb-1Cre mice and wild-type littermates 
as well as between R26FOG-1:mb-1Cre mice and wild-type littermates. The 
B220 quantification was performed by FACS within the lymphocyte population 
of the 2 different types of mice. In male cFOG-1KO:mb-1Cre mice, the 
B220high cell population was increased by 25% (Fig. 20A). These results were 
confirmed in independent experiments (2 males and 2 females cFOG-
1KO:mb-1Cre mice exhibited an increase in B220high cells or mature B cells). 
Nevertheless, in some of the experiments, cFOG-1KO:mb-1Cre mice 
surprisingly exhibited a decrease in B220high cells (1 male and 2 females). On 
the contrary, in male R26FOG-1:mb-1Cre mice, the B220high cell population was 
decreased by around 70% (Fig. 20B). In independent experiments, female 
R26FOG-1:mb-1Cre mice exhibited a decrease in B220high cell population (n=5). 
Besides, out of independent experiments, we observed that male cFOG-1KO: 
mb-1Cre mice showed less Pre B cells than the control mice (n=3). On the 
contrary, female cFOG-1KO:mb-1Cre mice exhibited Pre B lymphoma (n=3). 
Further investigations would be required to statistically demonstrate the 
relevance of these phenotypes and to fully define them. A bone marrow 
transplantation assay should help to figure out how primary B cells deleted for 
FOG-1 react and develop in an entire organism. This could also be 
considered with primary B cells overexpressing FOG-1 under the Rosa26 
locus. As discussed in the article “Inappropriate expression of FOG-1 does 
not affect B-cells but reduces the number of circulating eosinophils”, since 
targeted Rosa26 homozygous mice are viable and appear normal, the 
expression level of the transgene could be doubled by generating R26FOG-
1/R26FOG-1 homozygous mice (Soriano, 1999). 
Considering that Pre BI cells are firmly committed to become B220high 
cells (Welner et al., 2008), in vitro cultures of primary Pre BI cells showed 
results consistent with the previous data. Indeed, male Pre BI cells knock-out 
for FOG-1 showed an increase in proliferation compared to the control cells 
whereas male overexpressing FOG-1 Pre BI cells exhibited a growth defect 
compared to the control cells (Fig. 20C, D). These observations were 




















Figure 20 : Phenotypic analyses of lymphocyte population. (A) Cell surface expression of B220 was analyzed by flow 
cytometry in lymphocyte population of control and cFOG-1KO:mb-1Cre mice. (B) Cell surface expression of B220 
was analyzed by flow cytometry in lymphocyte population of control and R26FOG-1:mb-1Cre mice. Graphs 
representative of several experiments are shown. (C) Growth curve of Pre BI cells isolated from control and cFOG-
1KO:mb-1Cre mice. (D) Growth curve of Pre BI cells isolated from control and R26FOG-1:mb-1Cre mice. Orange 














in experiments involving female mice or a mixture of male and female mice 
(data not shown). 
It is noteworthy that 4 males and 1 female cFOG-1KO:mb-1Cre mice 
showed a decrease in spleen weight. Paler spleens were observed in cFOG-
1KO:mb-1Cre mice. 
This is reminiscent of the phenotypes observed for GATA-1.05/X mice 
which carry an allele that express GATA-1 at approximately 5% of the normal 
level. Indeed, these mice suffer from two distinct types of acute leukemia, an 
early-onset c-Kit positive nonlymphoid leukemia and a late-onset B 
lymphocytic leukemia (Shimizu et al., 2004). It is noteworthy that the ages of 
onset of leukemia are markedly different between the mice with nonlymphoid 
leukemia and those with B cell leukemia. The average age of onset of mice 
with c-Kit+/CD19- leukemia is 143 days after birth, whereas that of mice with c-
Kit-/CD19+ leukemia is 387 days. In this paper, they claimed that residual 
GATA-1 activity in GATA-1.05/X mice is necessary for the propensity to 
develop leukemias. Even if GATA factors are below detectable level in B cells, 
knockdown of FOG-1 from early stages of B cell development changes the 
balance normally observed between FOG-1 partners. For instance, FOG-
1/GATA-1, FOG-1/Ikaros and GATA-1/Ikaros stoechiometries could be 
displaced. It is therefore plausible that the targeted knockdown or 
overexpression of FOG-1 creates a situation where the differentiation 
potential of the precursor is shifted and an environment permissive for the 
transformation of normal B cells. 
 
2. Microarray experiments  
 
Cellular proliferation and differentiation are 2 different aspects of the 
development, corresponding to a dynamic equilibrium. To assess whether 
primary Pre BI cell differentiation was impaired in cFOG-1KO:mb-1Cre mice 
or in R26FOG-1:mb-1Cre mice, we performed different microarray analysis. 
 
2.1. On primary Pre BI cells isolated from R26FOG-1:mb-1Cre 
mice 
 
The microarray analysis realized using stringent conditions (P-value: 
0.01, Absolute linear fold change: 2.0) on primary Pre BI cells isolated from 
R26FOG-1:mb-1Cre mice revealed a change in expression of 99 genes 
compared to control Pre BI cells (Fig. 21 and Table 1). Among these 
misregulated genes, 78 genes were downregulated and 21 genes were 
upregulated. Of great interest, some contained several Ikaros binding sites in 
their promoter: for instance, Lrrn4cl and Ctse were upregulated in Pre BI cells 
with enforced expression of FOG-1; on the contrary, Gbp6 and Sh2d5 were 
downregulated in Pre BI cells overexpressing FOG-1. Moreover, at least 19 
genes, which were misregulated in the Pre BI cells with enforced expression 
of FOG-1, exhibited GATA factor binding sites in their promoter. Ctsa, Capg, 
Cdc42ep4, Sgpl1, Plk2, Zfand2a and Klf3 are some examples of such 
upregulated genes in Pre BI cells overexpressing FOG-1. Klf3, whose product 
binds to the CACCC box of erythroid cell-expressed genes and may play a 



















Figure 21 : Gene expression profiles of Pre BI cells with enforced expression of FOG-1 compared to control cells. 
After extraction from bone marrows of 2 males R26FOG-1:mb-1Cre mice and from 2 male control animals, B220+, 
CD19+, NK1.1+, c-kit+ and 493+ cells considered as Pre BI cells were sorted. The cells were put back in culture for 4 
days after seeding. Ctrl1, 2 and 3 stand for Pre BI cells that do not express the Cre under the mb-1 promoter and 









Ubash3a, Aspm, Pdxp, Btbd10 and Zdhhc2 were downregulated in Pre BI 
cells with enforced expression of FOG-1. More interestingly, Tiam1 (T cell 
lymphoma invasion and metastasis 1), Irf1 (Interferon regulatory factor 1) and 
Pde8a (Phosphodiesterase 8A), a gene involved in immune cell activation 
were also downregulated in Pre BI cells isolated from R26FOG-1:mb-1Cre mice. 
Additionally, interesting epigenetic regulator genes, Sap30 and Hist1h4c were 
identified as downregulated genes in the array. Besides, Emp3, Fgfrl1 and 
Tob1, three genes involved in cell proliferation were upregulated in Pre BI 
cells overexpressing FOG-1. In addition, Fgfrl1 and Tob1 have been shown to 
have a negative effect on cell proliferation. Otherwise, Sema4d, Sema7a, Tfpi, 
Spint2, Tnfsf10, Pbk and Fermt3, which were downregulated in Pre BI cells 
with enforced expression of FOG-1, are genes important for blood function 
and immune responses. More specifically, Lat and Sit1 also found 
downregulated in Pre BI cells overexpressing FOG-1, have been shown to be 
required for proper T cell signalling. Abtb1, another downregulated gene has 
been shown to play a role in developmental processes. Finally, three genes 
encoding epigenetic factors exhibiting enzymatic activities were identified as 
misregulated genes in Pre BI cells overexpressing FOG-1: Kdm5b (Lysine-
specific demethylase 5b) was upregulated, whereas Men1 (Multiple endocrine 
neoplasia 1) and Hdac2 (Histone deacetylase 2) were downregulated in Pre 
BI cells isolated from R26FOG-1:mb-1Cre mice. 
 
2.2. On primary Pre BI cells isolated from cFOG-1KO:mb-
1Cre mice 
 
The microarray analysis realized using stringent conditions (P-value: 
0.0001, Absolute linear fold change: 2) on primary Pre BI cells isolated from 
cFOG-1KO:mb-1Cre mice revealed a change in expression of 22 genes 
compared to control Pre BI cells (Fig. 22 and Table 2). Among these 
misregulated genes, 9 genes were downregulated and 13 genes were 
upregulated. Of great interest, Fmn2 a gene already known to be expressed 
during B cell development (in GC B cells) was downregulated in Pre BI cells 
KO for FOG-1. Rgs18 was another interesting gene downregulated in the Pre 
BI cells KO for FOG-1. It is noteworthy that these two latter genes contain 
regulatory GATA-1 binding sites in their promoter. Finally, Prelid2, a gene 
involved in mouse embryonic development was also downregulated in Pre BI 
cells KO for FOG-1. Ptpn3, Ms4a6b, Tlr7, Itgam and Zhx2 were some of the 
genes found upregulated in the array. Ptpn3, Ms4a6b and Zhx2 were genes 
notably involved in T cell development regulation. Itgam encodes a receptor 
known to play a role in B cell development. It has been shown to be 
expressed in precursor B cell acute lymphoblastic leukaemia. This experiment 






























Table 1: List of a number of genes found misregulated in the microarray performed in Pre BI cells overexpressing 















2.3. FOG-1 target genes in primary Pre BI cells 
 
A comparison of the gain (R26FOG-1 mice) and loss-of-function (cFOG-
1KO mice) analysis reveals an overlap of genes that are reciprocally 
regulated in both experimental approaches. They are downregulated in 
primary Pre BI cells isolated from R26FOG-1:mb-1Cre mice and they are 
upregulated in primary Pre BI cells isolated from cFOG-1KO:mb-1Cre mice. 
These genes, namely Hdac2, Igll1, Ikzf3 and Rag1 can be regarded as direct 
FOG-1 targets with high confidence. 
 HDAC2 has already been shown to play a role in B cells in different 
biological systems. In the chicken DT40 cell line, HDAC2 controls the amount 
of the IgM H-chain at the steps of both transcription of its gene and alternative 
processing of its pre-mRNA (Takami et al., 1999). In this system, HDAC2 
downregulates IgM light chain gene promoter activity (Takechi et al., 2002) 
and modulates immunoglobulin gene conversion frequency and distribution 
(Lin et al., 2008). Experiments in the B cells of conditionally targeted mice for 
HDAC1 and HDAC2 demonstrated that B cell development strictly requires 
the presence of at least one of these enzymes. When both enzymes are 
ablated, B cell development is indeed blocked at an early stage, and the rare 
remaining Pre B cells show a block in G1 accompanied by the induction of 
apoptosis (Yamaguchi et al.). 
Igll1 encodes one of the surrogate light chain subunits, lambda5 and is 
a member of the immunoglobulin gene superfamily. The Pre B cell receptor is 
found on the surface of Pro B and Pre B cells, where it is involved in 
transduction of signals for cellular proliferation, differentiation from the Pro B 
cell to the Pre B cell stage, allelic exclusion at the Ig heavy chain gene locus, 
and promotion of Ig light chain gene rearrangements. Ikaros proteins regulate 
the Pre BCR component lambda5 in a stage-specific manner. In Pre BI cells, 
Ikaros modulated lambda5 expression in competition with the transcriptional 
activator EBF. At the transition from the Pre BI to Pre BII stage, the 
expression of the Ikaros family member Aiolos was upregulated and required 
for the efficient silencing of Igll1 (Thompson et al., 2007). 
Ikzf3 encodes Aiolos a transcription factor that plays an important role 
in the regulation of lymphocyte differentiation. It plays an essential role in 
regulation of B cell differentiation, proliferation and maturation to an effector 
state (Wang et al., 1998). Notably, Aiolos is upregulated in chronic 
lymphocytic leukaemia (Duhamel et al., 2008). Aiolos together with Ikaros 
inhibit Pre B cell proliferation by directly suppressing c-Myc expression (Ma et 
al.). 
Rag1 is a catalytic component of the Rag complex, a multiprotein 
complex that mediates the DNA cleavage phase during V(D)J recombination 
(Grundy et al., 2009). In the Rag complex, Rag1 mediates the DNA-binding to 
the conserved RSS and catalyzes the DNA cleavage activities by introducing 
a double-strand break between the RSS and the adjacent coding segment. 
The Rag complex also plays a role in the Pre B cell allelic exclusion, a 
process leading to expression of a single immunoglobulin heavy chain allele 
to enforce clonality and monospecific recognition by the BCR expressed on 





















Figure 22 : Gene expression profiles of Pre BI cells KO for FOG-1 compared to control cells. After extraction from 
bone marrows of 2 males cFOG-1KO:mb-1Cre mice and from 1 male control animal. Ctrl1, 2 and 3 stand for Pre BI 
cells that do not express the Cre under the mb-1 promoter and therefore are not deleted for FOG-1 expression. FOG-












































































































Table 2 : List of a number of genes found misregulated in the microarray performed in Pre BI cells deleted for FOG-1. 
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ACF Chromatin-Assembly Factor 
AFC Ab-Forming Cell 
Ag Antigen 
AID Activation-Induced Deaminase 
Aire Autoimmune regulator 
APC Ag Presenting Cell 
BAFFR B cell Activating Factor Receptor 
BCL-6 B Cell Lymphoma 6 
BCR B Cell Ag Receptor 
bHLH basic Helix-Loop-Helix 
Blimp-1 B lymphocyte induced maturation protein 1 
bp base pair 
btk Bruton’s tyrosine kinase 
CD Cluster of Differentiation 
CDR Complementarity Determining Region 
C/EBP CAAT Enhancer Binding Protein 
CFU-MK Colony-Forming Unit-MegaKaryocytes 
CHD Chromodomain Helicase DNA binding protein 
CHRAC Chromatin Accessibility Complex 
CLP Common Lymphoid Progenitor 
CMJ Cortico-Medullary Junction 
CMP Common Myeloid Progenitor 
CSR Class Switch Recombination 
CtBP C-terminal Binding Protein 
CTD C-Terminal Domain 
cTEC cortical Thymic Epithelial Cell 
CXCL13 CXC-chemokine Ligand 13 
DC Dendritic Cell 
DN Double Negative 
DNA DeoxyriboNucleic Acid 
DNA-PK DNA-dependent Protein Kinase 
DP Double Positive 
DSB Double Strand Break 
EBF Early B cell Factor 
Elf-1 E74-like factor 1 
ES Embryonic Stem cell 
ETP Early T cell Progenitor 
FACS Fluorescence-Activated Cell Sorting 
FOG-1 Friend Of GATA-1 
FR Framework Region 
GC Germinal Center 
GMP Granulocyte/Monocyte Progenitor 
granB granzymeB 
GTF General Transcription Factor 
HDAC Histone Deacetylase 
HLH Helix-Loop-Helix 




HS Hypersensitive site 
HSC Haematopoietic Stem Cell 
IFN-γ Interferon-gamma 
Ig Immunoglobulin 
Igh Ig heavy chain gene 
Igll1 Immunoglobulin lambda-like polypeptide 1 
IgM Immunoglobulin M 
IKKβ Inhibitor of nuclear factor Kappa-B Kinase subunit beta 
IL Interleukin 
iNKT invariant Natural Killer T 
Inr Initiator 
IRF Interferon-Regulatory Factor 
ISP Immature Single Positive 
kb kilobase 
LCR Locus Control Region 
Lef-1 Lymphoid enhancer binding factor 1 
LPS Lipopolysaccharide 
LSD1 Lysine (K)-Specific Demethylase 1 
M Myeloid 
Mac-1 Macrophage receptor 1 
MAR Matrix Attachment Region 
MBD Methyl-CpG-Binding Domain 
MEP Megakaryocyte/Erythroid Progenitor 
MHC Major Histocompatibility Complex 
MITF Microphtalmia-associated Transcription Factor 
MK Megakaryocyte 
mRNA messenger RNA 
MTA Metastasis-Associated 
mTEC medullary Thymic Epithelial Cell 
MZ Marginal Zone 
MZ B Marginal Zone B cell 
NF-κB Nuclear Factor-kappaB 
NHEJ Non-Homologous End Joining 
NK Natural Killer 
NKT Natural Killer T cell 
NuRD Nucleosome Remodeling and Deacetylase complex 
NuRF Nucleosome Remodelling Factor 
p mast cell protease 
OBF-1 Oct-Binding Factor 1 
PALS Periarteriolar Lymphoid Sheath 
PAX-5 Paired box protein 5 
PCR Polymerase Chain Reaction 
PIC Pre-Initiation Complex 
Pol RNA Polymerase 
PRC2 Polycomb Repressive Complex 2 
Pre B cell B cell Precursor 
Pro B cell B cell Progenitor 
Rag Recombination activating gene 
RbBP Retinoblastoma-associated Binding Protein 




RBP-Jκ Recombination signal Binding Protein for Ig kappa J region 
rRNA ribosomal RNA 
RNA RiboNucleic Acid 
RSS Recombination Signal Sequence 
S1PR1 Sphingosine 1-Phosphate Receptor 1 
SCZ Subcapsular Zone 
SHM Somatic Hypermutation 
SOX4 Sex-determining region Y box 4 
SP Single Positive 
Stat6 Signal transducer and activator of transcription 6 
TACC3 Transforming Acidic Coiled-Coil 3 
TAFn TBP-Associated Factor 
TBP TATA-Binding Protein 
TCR T Cell Ag Receptor 
TdT Terminal deoxynucleotidyl Transferase 
Th T helper cell 
tph tryptophan hydroxylase 
tRNA transfer RNA 
XBP-1 X-Box-binding Protein 1 
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